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1-1- INTRODUCTION 
Theories concerning the etiology of psychosis have, over the 
last century, focussed upon environmental, cultural, sociologi-
cal, psychological, morphological, biological and biochemical 
factors which may predispose an individual to the development of 
a psychosis (Barker, 1980). While there is to some extent suppor-
ting evidence for each hypothesis, no single idea has been gene-
rally accepted. This has led to the description of psychosis as a 
heterogenous disease or syndrome with many possible etiologies. 
During the last fifty years reproducible results from different 
disciplines have begun to yield clues to some of the possible 
biochemical processes involved in this group of diseases (Smy-
thies, 1982). There has been a constant refinement of diagnostic 
procedures and a better clinical understanding of the symptoma-
tology associated with the disease. At present it seems likely 
that the term psychosis still applies to a group of etiological-
ly separate but symptomologically similar diseases. Therefore, 
several biochemical theories on the etiology of psychosis co-
exist, each of which is more or less supported by experimental 
evidence, despite these theories being somewhat contradictory at 
first glance (Barker, 1980). 
In paragraph 1.2 of this chapter, some hypotheses of psycho-
sis related to the one-carbon cycle, are described. In paragraph 
1.2.1. and 1.2.2. the transmethylation and one-carbon cycle hypo-
thesis are respectively described, as originally put forward by 
Osmond and Smythies (1952). These hypotheses suggest a faulty 
methylation of biogenic amines in the one-carbon cycle, or an al-
tered activity of some of the enzymes in this cycle, as a possi-
ble cause of schizophrenia. In paragraph 1.2.3. possible pathways 
in mammals for the formation of beta-carbolines 1 potentially 
hallucinogenic compounds, are described. In the last part of 
paragraph 1 .2. some metabolic aberrations in serine metabolism 
are described in a group of patients suffering from an acute 
psychosis of the manic psychedelic type (Pepplink.huizen, 1983), 
giving support to the hypothesis that hallucinogenic compounds 
could be formed endogenously during acute psychosis. It was 
hypothesized that a disturbance in the serine- and glycine meta-
bolism could give rise to excess formation of formaldehyde, and 
thus possibly to the formation of tricyclic compounds with a 
beta-carboline structure (see Fig. 1 ), some of which have known 
hallucinogenic properties. The occurrence of beta-carbolines in 
man and rat is described in paragraph 1.3. The last part of this 
chapter gives a description of the methods which have been used 
to investigate whether the metabolic alterations in the serine-
1 0 
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and glycine metabolism can evoke behavioural disturbances in 
rats, and whether these compounds are actually being formed in 
this animal model, as well as a description of the methods used 
to measure beta-carbolines in man during psychosis. 
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Fig. 1. A: beta-carboline (BC) and B: 1 ,2,3,4-tetrahydro-beta-
carboline (THBC) parent structure. 
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1 • 2 • HYPOTHESES OF PSYCHOSIS RELATED TO THE ONE-CARBON CYCLE 
1.2.1. The transmethylation hypothesis-
All transmethylation reactions of biogenic amines in the 
mammalian body receive methyl groups via S-adenosylmethionine, 
(SAM), generated in the one-carbon cycle, as depicted in Fig. 2. 
SAM is synthesized from adenosine and methionine by the enzyme 
12 
CH( 
X 
SAH 4 ~ SAM 1 
2 1 
3 
14 
HCYS ( \ ~MET 
CH 3-B12 8 12 
3 
SER GLY 
Fig. 2 _ 'Ihe one-carbon cycle. 
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methionine adenosyl transferase (MAT). The most important one-
carbon donor is serine, by conversion to glycine, forming methy-
lenetetrahydrofolic acid (CH2=FH 4 ). This compound is dehydroge-
nated to methyltetrahydrofolic acid, which can donate it's me-
thylgroup to S-adenosylhomocysteine (SAH) in a vitamin B12-depen-
den t reaction. 
The original transmethylation hypothesis of schizophrenia 
(Osmond and Smythies, 1952) was based on the fact that mescaline, 
a psychotogenic compound, showed a structural resemblance to a-
methylated cathecholamines. They suggested that a disturbance of 
brain catecholamine methylation could lead to the formation of 
psychotogenic substances by an overactive transmethylation sys-
tem. In 1961, Pol lin et aL discovered that oral administration 
of methionine in schizophrenic patients could evoke psychopatho-
logical effects, and/or a superimposed toxic psychosis in schizo-
phrenic patients. These findings were confirmed by several other 
investigators, as reviewed by Cohen et al. (1974), who concluded 
that the administration of methionine has profound effects on 
mood and perception in 40 % of chronic schizophrenics. These 
findings supported the transmethylation hypothesis to some ex-
tent, because methionine is the main precursor of SAM, an impor-
tant methyldonor (Fig. 2). The authors concluded that an aberrant 
transmethylation of biogenic amine precursors could play some 
role in the pathogenesis of schizophrenia (Cohen et al., 1974). 
Many of the methionine-loaded schizophrenics did not manifest the 
symptoms described above within several hours, as would be expec-
ted after the endogenous formation of "psychotogenic" compounds, 
but only after several days of chronic administration of this 
amino acid. However, the effects exerted by methionine may point 
to some basic fault in the transmethylation mechanisms in the 
one-carbon cycle (Smythies, 1982). 
The hypothesis of methylation disorder was given support by 
Brune and Himwich (1962), who obtained comparable results after 
substitution of betaine for methionine in the loading experiment. 
Betaine is also a methyldonor, but of a chemical family quite 
different from methionine. 
As reviewed by Smythies (1984a), the transmethylation hypo-
thesis was extended to include the production of abnormal hallu-
cinogenic metabolites of serotonin or tryptamine, viz. dimethyl-
tryptamine (DMT) and 0-methyl bufotenine (OMB, Fig. 3) of which 
the latter is known to be hallucinogenic in man (Gillin, 1978). 
Several aberrations in one-carbon methylation mechanisms have 
been found since (Smythies, 1984a). It has been shown that SAM 
is a source of methyl groups for the enzymatic methylation of 
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hydroxyl- and nitrogen groups of biogenic amines in lung tissue 
(Axelrod, 1961). Also, methionine and SAM were supposed to be the 
indirect and direct methyl donor in N,N-dimethylations of seroto-
nin and tryptamine, forming bufotenine and dimethyltryptamine, 
respectively (DMT, Axelrod, 1961; Mandell and Morgan, 1971 ). It 
has been reported that an enzyme, found in human brain could 
synthesize DMT from tryptamine via a transmethylation reaction 
(Mandell and Morgan, 1971). Another line of possible evidence was 
provided by Poitou (1974), who found that cathecholamine-0-methyl 
transferase was elevated in red blood cell ghosts in schizophre-
nics, but these results could not be replicated by others (Gil-
lin, 1978). 
parent amine 
-R 
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-CCH3 
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dopamine dimethoxyphenylethylamine (DMPEA) 
Fig. 3. Putative hallucinogenic comt=aunds and their precursors 
formed by methylation processes. 
Until now, the search for psychotogenic compounds which 
could be endogenously formed by an increased one-carbon cycle 
activity has not been very succesfuL Although DMT and OMB have 
been identified in human CSF and rat brain by gas-chromatography/ 
mass-spectrometry (GC/MS, Smythies et aL, 1979), and in urine 
using a GC technique (Oon et al., ~ 977), no differences between 
schizophrenics and normal controls were found. Moreover, much 
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higher amounts of DMT were excreted into urine in cases of liver 
disease without psychosis (Checkley et aL, 1979). In addition, 
rat brain DMT and OMB are known to be increased significantly by 
the induction of stress, and this increase could be prevented by 
adrenalectomy (Beaton and Christian, 1978; Harrison, 1982). This 
suggests a physiological role of DMT and OMB related to stress 
rather than to psychosis (Smythies, 1983) . Other studies have 
shown that methionine administration did not increase urine 
levels of methylated metabolites of cathecholamines in man {An-
tun et aL, 1971), nor did it increase the production of DMT in 
rat brain after methionine or SAM administration. It actually 
decreased the production of DMT by rabbit lung (Stramentinoli and 
Baldessarini, 1978). This was in accordance with the findings of 
3aldessarini ( 1978), which indicated that excess methionine in 
fact inhibits transmethylation, which was explained by the fact 
that SAH, one of the products of the transmethylation reaction 
(Fig. 2), is a potent product inhibitor. Therefore, it can be 
concluded that there is no existing evidence which shows that 
putative endogenous hallucinogens can be formed as a result of 
aberrant transmethylation reactions (Smythies, 1983). 
1.2.2. The one-carbon cvcle hypothesis. 
In 1963 the transmethylation hypothesis was modified into 
the one-carbon cycle hypothesis, which suggested a fault in the 
methylation process itself, rather than in the formation of 
psychotogenic products (Smythies, 1963). Carl et aL (1978) 
showed that the Vmax of methionine adenosyltranferase (MAT) and 
that of serine hydroxymethyltransferase (SHMT, Fig. 2) are signi-
ficantly reduced in a group of schizophrenics, whereas two other 
enzymes of the one-carbon cycle did not differ in activity from 
controls. However, patients low in MAT activity were not the 
same as those low in SHMT activity, which points to different 
schizophrenic subgroups. Israelstam et aL (1970) determined the 
overall rate of transmethylation by measuring the evolution of 
14co2 after administration of 
14c-methionine. It was found that 
this process was slower in schizophrenic patients when compared 
to controls, whereas it was much faster in depressives, which 
were on tricyclic anti-depressant therapy. Ismail et al. {1978) 
confirmed these findings in schizophrenics using in vitro experi-
ments, showing a decreased oxidation of the methyl-carbon of 
methionine in the leukocytes of schizophrenic patients. These 
results suggested that schizophrenia and depression can be asso-
ciated in some cases with an underactive methylation system, 
rather than with the formation of abnormally methylated products 
as a result of increased activity of the one-carbon cycle (Ismail 
15 
Chapter I 
et aL, 1978). 
More evidence that methylation processes may be altered in 
some affective disorders was collected by Fazio et aL ( 1976), 
who used S-adenosylmethionine (SAM) to investigate the transme-
thylation hypothesis. They noted that SAM had antidepressant 
properties. Further studies indicated that both unipolar and 
bipolar depressives also had a significantly lowered MAT func-
tion, whereas the Vmax for MAT was elevated in four of six manic 
patients (Tolbert et al., 1983). These changes were not influen-
ced by neuroleptic medication, age or sex variables. They have 
suggested that those depressed patients who respond to SAM are 
those with a low Vmax for MAT. In addition, SAM not only has 
antidepressant properties, but can also cause a switch into mania 
in bipolar patients. It has been suggested that some depressives 
react to SAM because of defective production of their own SAM due 
to low MAT activity, and that mania may be associated with high 
MAT activity (Tolbert et aL, 1 984; Smythies, 1984b). Further-
more, it was suggested that the exacerbative effect of methionine 
in schizophrenic patients may be a manic reaction superimposed on 
the schizophrenic process (Tolbert et aL, 1984). 
In conclusion, the former idea that an aberrant methylation 
of biogenic amines through an increased activity of one-carbon 
cycle enzymes is involved in the etiology of schizophrenia is 
not supported by biochemical findings. However, decreased activi-
ty of MAT and SHMT was found in schizophrenic subgroups, as well 
as an antidepressant effect of SAM in depressed patients, which 
indicates that alterations in the kinetics of the transmethyla-
tion system in the one-carbon cycle may play an important role in 
schizophrenia and affective illness. 
1.2.3. How can hallucinogenic compounds be formed? 
As described above, since Osmond, Harley-Mason and Smythies 
have put forward their transmethylation hypothesis, no evidence 
has become available that hallucinogenic compounds are formed 
endogenously during psychoses (Smythies, 1984b). Although some 
compounds like DMT, OMB and also dimethoxyphenylethylamine 
(DMPEA, the 'pink spot') have been detected in the urine of 
schizophrenics, these results were irreproducible by others or 
the amounts found were not different from normal values (Gillin 
et aL, 1978). 
In order to find a biochemical rationale for the exacerba-
tive effect of methionine in schizophrenic patients, several 
1 6 
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enzymes were described which could be responsible for the forma-
tion of hallucinogenic compounds during psychosis. Axelrod (1961) 
described an enzyme isolated from rabbit lung which could convert 
tryptamine to DMT using SAM as a rnethyldonor. Mandell and Morgan 
(1971) reported the presence of an indoleethylamine N-methyl-
transferase in human brain, which also used SAM as the methyldo-
nor and Laduron (1972) descri~ed an N-methyltransferase with 
methyl tetrahydrofolic acid (CH 3 -FH 4 ) as a methyl donor. These 
mechanisms could explain the methionine effect in two ways: (1) 
Methionine can be converted to SAM, which can act directly as a 
methyl donor in N- or 0-methylation of catecholamines or indole-
amines, and (2) methionine can inhibit the methylation of homo-
cysteine, which may result in accumulation of CH 3 -FH4 (Fig. 2). 
The excessive production of these two methyldonors could thus 
account for the formation of hallucinogenic compounds via aber-
rant methylation reactions. However more careful studies of the 
reaction mechanism revealed that NS,N10-methylenetetrahydrofolic 
acid (CH2=FH4 ) instead of CH3-FH4 is the ultimate methyl donor in 
this pathway (Meller et aL, 1975). This compound can be formed 
by the reverse reaction of N5,N10-methylenetetrahydrofolate re-
ductase, and can non-enzymatically decompose in tetrahydrofolic 
acid and formaldehyde. The latter compound can condense in the 
so-called Pictet-Spengler reaction with indoleethylamines or 
cathecholamines forming tetrahydro-beta-carbolines (THBC) or 
tetrahydroisoquinolines (THIQ), respectively (Fig. 4, Leysen and 
Laduron, 1974; Pearson and Turner, 1975; Taylor and Hanna, 1975). 
indo lee thy lamine 1 ,2,3,4-tetrahydro-beta-carboline 
pheny lethy lami:ne 1,2,3,4-tetrahydroisoquinoline 
Fig. 4. The Pictet-Spengler reaction. 
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Indeed, careful· analysis of the reaction products using CH3-FH4 
as the methyldonor showed that these were not the expected N- or 
0-methylated indoles, but tetrahydro-beta-carbolines (Mandel 
et al., 1974). These results are in agreement with the suggestion 
made by Bruinvels (1975), that CHz=FH 4 , rather than CH 3 -FH 4 , is 
involved in the development of acute psychotic effects in schizo-
phrenic patients. 
The Pictet-Spengler reaction between indoleethylamines and 
some aldehydes, depicted in Fig. 4, has been known for several 
decades, and it was shown by Hahn and Ludevig (1934) that this 
reaction occurs easily at physiological conditions (37 °C and 
neutral pH). More support for the suggestion that CH2=FH4 is the 
methyldonor in aberrant methylating reactions was gained by the 
findings of Pearson and Turner (1979) who revealed that THBC can 
be formed by incubating partially purified serine hydroxy-
methyltransferase (SHMT) with serine, FH4 and tryptamine. Under 
the conditions used, the beta-carbon of serine is transferred to 
FH4 forming CH2=FH4, which yielded THBC as described above. These 
findings gave support to the early hypothesis of Mcisaac (1961), 
who was the first to postulate that endogenous formation of beta-
carbolines could be involved in mental diseases, as well as to 
the hypothesis that 'hyperformaldehydism' may be involved in the 
etiology of schizophrenia (Fig. 5; Barker, 1980). 
HCHO dimethylglycine 
sarcosine 
serine 
glycine._ ______________________ __-
Fig~ 5. Formation of formaldehyde in the mammalian b::::d.y. 
1.2.4. The serine hypothesis. 
In 1980, Pepplinkhuizen et al. described four patients suf-
fering from schizophrenia-like psychosis which resembled closely 
18 
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a hallucinogenic drug-induced state. These patients were suspec-
ted of having a porphyric disease, which was held responsible for 
a disturbed serine and glycine metabolism (Fig. 6). Oral loading 
tests using 2 mmol serine per kg body weight resulted in acute 
psychedelic or psychotic symptoms within 5 hours, and lasted for 
3-6 hours. Decreased excretion of serine into the urine was 
measured in these patients, suggesting increased consumption of 
this amino acid. During later experiments, on the basis of hourly 
measured amino acid plasma levels over a period of 6 h after oral 
serine- or glycine loading tests, altered serine- and glycine 
plasma levels were found when compared with controls. These 
findings, which were in some cases coupled with acute porphyria, 
may be responsible for an increased formation of CH2=FH4 (Bruin-
vels et al., 1980). In acute porphyria, the biosynthesis of 
delta-aminolevulinic acid (d-ALA) is strongly enhanced. Since d-
ALA is synthesized from glycine and succinyl-CoA (Fig. 6), the 
demand for glycine will be increased under these circumstances. 
Consequently, more serine is converted into glycine via serine 
hydroxymethyltransferase (SHMT) using FH 4 as a cofactor, which 
will concomitantly increase the production of CH2=FH4. This thee-
SER X 
CYST SAH SAM 
• • t CYS HCYS MET 
... CH3-B12 8 12 TAU ~ .../ 
:::r::: J FH 4 
SER GLY 
Suc-CoA 
------~------•6-ALA 
~ 
r 
HAEM 
Fig. 6. Metabolic relationships between taurine- and porphyrin 
pathways and the one-carb:m cycle. 
CYST = cystathionine 
CYS = cysteine 
Sue-GoA = succinyl-OoA 
d-ALA = delta-aminolevulinic acid 
PBG = pc:>rphobilinogen 
TAU = taurine 
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ry was supported by the beneficial effects of treatments which 
are also used in the treatment of acute porphyria, ~the con-
sumption of carbohydrate-rich diet and administration of glucose, 
which were found to be superior to treatment with neuroleptics 
(Pepplinkhuizen, 1983). In one patient, treatment with vitamin 
B12 , which has also benificial effects in porphyric diseases, im-
proved psychotic symptoms as well. In the same patient, both 
psychotic and porphyric symptoms were precipitated after treat-
ment with barbiturates (Pepplinkhuizen, 1983; Pepplinkhuizen and 
Wunder ink, 1 985 ). Moreover, the psychiatric symptoms which are 
often seen during acute porphyric attacks resembled the symptoms 
of episodic acute psychoses (Pepplinkhuizen and Wunderink, 1985; 
Goldberg and Stinnet, 1983). 
Oral administration of the amino acids serine or glycine to 
patients suffering from this type of psychosis revealed that the 
conversion of glycine to serine was impaired (Bruinvels and 
Pepplinkhuizen, 1984). Moreover, taurine plasma levels were in-
creased and serine plasma levels were decreased in fasting, 
serine-responsive, episodic psychotic patients (Bruinvels and 
Pepplinkhuizen, 1984). These results were interpreted as the 
increased taurine formation being the primary cause of the deran-
gement in serine-responsive patients, which in turn would lead to 
a decrease in serine plasma levels (Fig. 6). It was suggested 
that limited activity of methyltetrahydrofolate:hornocysteine 
methyltransferase in serine positive patients could result in the 
accumulation of CHz=FH 4 after serine loading of these patients (Fig. 6). This in turn would lead to the formation of tetrahydro-
beta-carbolines or tetrahydroquinolines via the dissociation of 
CHz=FH4 into formaldehyde and FH4 (Fig. 5) and the subsequent 
condensation with indoleamines or catecholamines, respectively 
(Fig. 4). These substances may be responsible for the psychiatric 
symptoms seen during acute psychotic attacks, or after serine 
loading in patients. It remains, however, to be shown ·whether 
hallucinogenic beta-carbolines or tetrahydroisoguinolines are 
indeed being formed during this type of episodic psychosis. 
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1 .3. OCCURRENCE AND EFFECTS OF beta-CARBOLINES IN MAMMALS 
Despite the fact that several metabolic aberrations in psy-
chotic and schizophrenic patients have been described , it has, 
until now, not been shown that hallucinogenic compounds, formed 
in mammalian species, could be held responsible for the psychia-
tric symptoms in these patients. General interest in beta-carbo-
lines has been increased since the proposal of Mcisaac (1961 a 
and b) that these compounds could be involved in the development 
of mental disease. This interest has mainly been prompted by the 
following findings: 
Ethnopharmacology_ Beta-carbolines are found in plants which 
have been used as hallucinogens by tribes living in various parts 
of South-America, Asia and Africa, who were familiar with the 
potent psychoactivity of several plants containing beta-carbo-
lines (Schultes, 1982, List and Hoerhammer, 1977; Naranjo, 1979). 
Also ancient Greeks and Europeans in our centuries have been 
~sing seeds of Peganum Harmala in the treatment of eye disease, 
as analgesicum and aphrodisiac, as a "truth serum", or as an 
antidepressive. These seeds contain several beta-carbolines, 
such as harmaline (7-Me0-1-Me-DHBC) 1 harmalol (7-0H-1-Me-DHBC) 
and harmine (7-Me-1-Me-BC) 1 among others (Fig. 7 1 Airaksinen and 
Kari 1 1981 I and II). West-American natives have used extracts 
from Passiflora species (edulis and incarnata) for several indi-
cations ~insomnia, spasms and cramps (Airaksinen and Kari, 
1981 II). Narcotic and hallucinogenic agents containing beta-
carbolines, which were prepared from the South-American lian 
banisteriopsis caapi and other plants of the Malpighiaceae, have 
been used by South-American Indians (Airaksinen and Kari 1 1981 
II). 
Hallucinogenic properties. Some pure beta-carbolines have 
known hallucinogenic properties. The largest study on the hallu-
cinogenic effects of these compounds in man has been carried out 
by Naranjo (1967, 1979) 1 who orally administered harmaline (7-
Me0-1-Me-DHBC)1 harmine (7-Me0-1-Me-BC), tetrahydroharmine (7-
Me0-1-Me-THBC), 6-methoxyharmalan (6-Me0-1-Me-DHBC) and 6-metho-
xytetrahydroharman (6-Me0-1-Me-THBC, see Fig. 7) to healthy vo-
lunteers. When the subjects had their eyes closed1 they described 
vivid, coloured imagery (closed eye imagery). When eyes were 
open, they described the superposition of images on walls or cei-
lings, or the viewing of imaginary scenes simultaneously with an 
undistorted perception of surrounding objects. Harmaline was 
found to be even more hallucinogenic than mescaline, which is the 
most visually acting drug in it's chemical group. Doses needed 
21 
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for these effects ranged from 4-15 mg/kg when administered oral-
ly. 
A 
::©DQ ::©oQ 
c~ c~ 
B C 
canpound structure -R1 -R2 
-OCH3 -H 
-0CH3 -H 
-OCH3 -H 
-H 
-OCH3 
-H -OCH3 
harmaline B 
harmine c 
tetrahydroharrnine A 
6-methoxyhaimalan B 
6-methoxytetrahydrohaiman A 
Fig. 7. beta -Car:tolines administered to humans. 
Physiological occurrence. Tetrahydro-beta-carboline- and 
beta-carboline derivatives have been detected in human and rat 
tissues and body fluids, as can be seen in Table 1 and 2. Beta-
carbolines and tetrahydro-beta-carbolines in man were mainly 
found in plasma and platelets. Considerable differences in con-
centration of some beta-carbolines were reported, even by the 
same group of investigators, which could be due to artifactual 
formation of beta-carbolines during the work-up procedures. Some 
doubt still exists as to their physiological occurrence, because 
these compounds are very easily formed from formaldehyde and 
indoleamines or catecholamines, as discussed by Eosin et al. 
(1983) and Bloom and Barchas (1982). It was shown by Eosin et aL 
(1983) that 6-0H-THBC can be formed during sample preparation due 
to the presence of formaldehyde in organic solvents. To the 
authors' knowledge, there is only one article reporting the 
measurement of beta-carboline in acute schizophrenic patients 
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Canpound locus cone dimension reference 
THBC platelets 5.8 J;Xll/1 o8 plat. Honecker 1978b 
" 
1 0.6 
" 
Kari 1979 
" 
0.5 
" 
Honecker 1980 
" 
20 
" 
Barker 1982 
plasma 31.4 + 5.1 J;Xll/ml Kari 1979 
urine 232 - "b163 J;Xll/sample Honecker 1978a 
6-0H-THBC platelets 2.7 + 0.3 J;Xll/108 plat. Rcmnelsp. 1982 
13.2 - J;Xll/sample Eosin 1983 
6-MeO-THBC platelets 7.5 J;Xll/1 o8 plat. Barker 1982 
plasroa 6.2 _±.1.7 J;Xll/ml Rimon 1984 
retina 9 J;Xll/gr Leino 1984 
6-0H-1-CH3-
THBC urine 5.1 .± 1 . 3 p:n/urn creat. Beck 1982 
1-Me-BC platelets detected Bidder 1979 
Table 1. beta-Carb:>lines (concentrations + standard error of the 
mean (SEM)) in human tissues and b::dy fluids (p:n=picanole; um=mi-
cromole; plat.= platelets; creat.= creatinine). 
Canpound locus cone dimension reference 
THBC brain 11.8+2.9 J;Xll/gr wet wt. Barker 1979 
" 
101.7 + 28.5 
" " 
1981 
" 
0.23-
" 
Johnson 1984 
forebrain 275 ;!:_ 78 
" 
Honecker 1978a 
6-0H-THBC platelets 275 + 129 J;Xll/1 o8 plat. Rommelsp. 1979 
3."2"- 6.9 
" " 
1982 
6-MeO--THBC brain 176 + 82 J;Xll/gr wet wt Barker 1981 
adrenal 5513 + 148 
" sh~er 197s arc. nucleus deteCted 
6-0H-1-CH3-
plasma J;Xll/ml plasma THBC 0.52 + 0.15 Beck 1983 
urine 3.6 + 1.0 J;Xll/24 hr 
" " faeces 0.9 + 0.1 pm/g~'liver " " liver 11.1 _:;:: 3.6 
" " 
1-Me-BC arc. nucl. 1300 J;Xll/ gr arc. nueL Shcemaker 1980 
Table 2. beta-Carbolines (concentrations + SEM) in rat tissues 
and body fluids (pm=pieomole; plat.= platelets). 
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(Rimon et al., 1984). This group has measured 'pinoline' or 6-
methoxy-1,2,3,4-tetrahydro-beta-carboline levels in serum and 
cerebrospinal fluid of schizophrenic patients. A detectable con-
centration of 6-MeO-THBC was always present, but no differences 
were found between the schizophrenic and the control groups. 
Besides, these values were not related to different subtypes of 
schizophrenia, or to the intensity of the psychopathological 
symptoms. 
Monoamine oxidase inhibition. Monoamine oxidase is the prin-
cipal enzyme concerned with the inactivation of serotonin (5-HT) 
and other neurotransmitters. Monoamine oxidase inhibitors have 
been used as antidepressants for several decades, and are thought 
to function via increases in availability of monoamine neuro-
transmitters at synapses in the central nervous system (Bowman 
and Rand, 1980). Low platelet monoamine oxidase (MAO) activity 
has been considered as a biological marker in schizophrenia, as 
reviewed by Siever and Coursey (1985). It has been found that 
there is a mild decrease in platelet MAO-activity among chronic 
schizophrenic groups, but not in acute schizophrenia. However, 
long-term neuroleptic medication and cigarette smoking have ap-
peared to be serious artifacts in this relationship. Moreover, 
MAO-activity did not vary with changes in clinical symptoms. 
Therefore, some doubt still exists on the value of MAO-activity 
as a biological marker (Siever and Coursey, 1985). Nevertheless, 
the observation that beta-carbolines are potent and selective 
MAO-inhibitors, is quite intriguing in this respect. The inhibi-
tory effect of beta-carbolines on MAO, mainly of the A-type, has 
been shown to be reversible and usually competitive (Airaksinen 
and Kari, 1981 II). In general, the unsaturated beta-carbolines 
are more potent MAO-inhibitors than the corresponding tetrahydro-
beta-carbolines, as shown in liver and brain tissue (Airaksinen 
and Kari, 1981 II). IC5o-values of the most potent MAO-inhibiting 
beta-carboline (harmaline) is about 10-8 M, and about 10-5 M for 
the most potent tetrahydro-beta-carboline (Buckholtz and Boggan, 
1977). Moreover, it has been shown in rats that the concentration 
of brain 5-hydroxyindoleacetic acid (5-HIAA) decreased after the 
administration of beta-carbolines, which suggests that beta-
carbolines in vivo may act by inhibition of MAO (Airaksininen and 
Kari, 1981 II). 
5-HT reuptake inhibition. A dysfunction in central serotonin 
(5-HT) metabolism in schizophrenia has been repeatedly suggested 
(DeLisi et al., 1981 ). Data have been obtained by measuring the 
concentrations of 5-HT and it's metabolites in urine and blood 
(Stahl et al., 1982), in post-mortem brain, in cerebrospinal 
fluid, and after administration to schizophrenic patients of 5-HT 
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precursors and/or drugs affecting central 5-HT turnover (De Lisi 
et al., 1981). It was concluded from these experiments that 
increased whole blood 5-HT concentrations in chronic schizophre-
nic patients could be used as a biological marker for schizophre-
nia. Therefore, it is interesting that beta-carbolines inhibit 
the 5-HT reuptake, 6-0H-THBC being the most active in synapto-
somes and 6-MeO-THBC in platelets, but only the latter slightly 
exceeding the potency of 5-HT. 1-Methylated THBCs and all DHBCs 
and BCs studied were less potent (Airaksinen and Mikkonen, 1980; 
Komulainen et aL, 1980; Rommelspacher et aL, 1978). Therefore, 
reuptake inhibition may be the mechanism by which beta-carbolines 
increase 5-HT concentrations in the synaptic cleft. The high 
selectivity of some beta-carbolines in increasing 5-HT concentra-
tions in rat brain may result from the combination of selective 
MAO-A and 5-HT reuptake inhibition, respectively, which allows 
them to inhibit brain MAO effectively only in 5-HT neurons (Ai-
raksinen and Kari, 1981 II). It was proposed by Langer et al. 
(1984) that 6-MeO-THBC may subserve the role of a hormone that 
modulates the neuronal uptake of 5-HT, and which is probably 
synthesized, stored and released by the pineal gland to fulfill 
this physiological function. They speculated that 6-MeO-THBC 
could play an important role in the pathophysiology of depres-
sion. 
Benzodiazepine receptor binding. The discovery of high affi-
nity, saturable and stereospeci~ic receptors for benzodiazepines 
in the mammalian central nervous system has led to an intensive 
search for endogenous factors that physiologically regulate this 
receptor (Cain et al., 1982). Although Braestrup et al. (1980) 
originally proposed beta-carboline-3-carboxylic acid ethyl ester 
(BCEE) as the endogenous factor, subsequent studies have shown 
that this compound is probably formed during the isolation and 
extraction procedure (Nielsen et al., 1982). However, it has now 
definitely been established that beta-carbolines have high affi-
nity for the benzodiazepine receptor (Cain et al., 1982). It has 
been demonstrated that BCEE antagonizes the anticonvulsant action 
of diazepam. Cain et al. (1982) have reported on the interactions 
of a series of beta-carbolines and tetrahydro-beta-carbolines 
with benzodiazepines in vitro. Beta-carboline-3-carboxylic acid 
propyl ester was most potent in displacing [ 3H]diazepam (Kr=1 
nM). Removal of the carbonyl substituent for the 3-position 
resulted in a decrease in affinity (Kr= 1.6 microM for norhar-
man). The introduction of a methyl group in the 1-posi tion fur-
ther decreased affinity for the benzodiazepine receptor (K1 = 12.4 
microM for harman). The corresponding saturated tetrahydro-beta-
carbolines are, in general, a hundred times less potent in benzo-
diazepine receptor binding than their non-saturated counterparts 
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(Cain et al., 1982). The observation that B-CEE elicits tonic and 
clonic convulsions in rodents, demonstrated that beta-carbolines 
not only antagonize the principal pharmacological actions of 
benzodiazepines, but also produce intrinsic actions which a~e 
more or less opposite to the benzodiazepines. These compounds 
have been termed "inverse agonists" or "active antagonists" 
(Skolnick et al., 1984b). Administration of B-CEE to chair-adap-
ted, male rhesus monkeys elicited anxious behaviour, which was 
suggested to be a reliable and reproducible model of human anxie-
ty (Skolnick et aL, 1984a). As shown by studies of Morin (1984), 
norharman produces kindled seizures when given daily at a subcon-
vulsive dose of 20 mg/kg intraperitoneally. These effects could 
be blocked by diazepam and other ligands of the bezodiazepine 
receptor. These results indicate that in vivo effects of beta-
carbolines are probably mediated by the benzodiazepine receptor 
(Morin, 1 984 I. 
Summarizingr there is evidence to suggest the presence of 
saturated and non-saturated beta-carbolines in mammalian tissues. 
However, this research may include artifactual formation of beta-
carbolines during work-up procedures. Besides, these compounds 
are pharmacologically very active as MAO-A inhibitors, 5-HT reup-
take inhibitors and inverse agonists or antagonists of the benzo-
diazepine receptor, suggesting a role as neuromodulator for these 
compounds. However, despite their interesting pathopharmacologi-
cal profile, there is as yet no evidence that these compounds are 
formed in substantial amounts during mental diseases. 
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1.4. METHODS OF INVESTIGATION 
Animal model for psychosis. As hypothesized above, an in-
creased conversion of serine into glycine, resulting in increased 
production of CH2=FH4, could give rise to the production of beta-
carbolines or tetrahydroisoquinolines via the reaction of formal-
dehyde with biogenic amines. 3ased on this hypothesis it was 
tried to develop an animal model in which the putative formation 
of these compounds could be measured and correlated with beha-
vioural disturbances. Induction of porphyria by chemical methods 
was used to increase the conversion of serine into glycine by 
induction of delta-aminolevulinic acid synthetase, the first 
enzyme in the heme pathway. It was assumed that cataleptic and/or 
catatonic behaviour could be used as an indicator for psychotic 
behaviour (Bloom et aL, 1972; Maxwell, 1968; Segal et aL, 1977 
and Chapter II). As described in chapter II, behavioural distur-
bances could indeed be measured in porphyric rats after serine or 
glycine treatment. 
Measurement of beta-carbolines in man and rat. As can be 
seen from Tables 1 and 2, beta-carbolines have been measured in 
human and animal tissues in variable quantities. However, these 
variations are probably due to the artifactual formation of 
formaldehyde during sampling, processing and quantitation of 
these tissue samples. To cope with these problems, a new method 
was developed in order to avoid the usage of chemicals or proce-
dures which could introduce formaldehyde into the samples. A 
description of this method is given in Chapter III. 
Formation of beta-carbolines in porphyric rats. In order to 
test the hypothesis that beta-carboline compounds are formed in 
rats during increased serine to glycine conversion, some of these 
compounds were measured in platelet rich plasma, using the method 
described in Chapter III. As described in Chapter IV, a non-
saturated beta-carboline was detected in platelet rich plasma 
after treatments described in Chapter II. 
Formation of beta-carbolines during psychosis. Despite the 
fact that many metabolic aberrations have been described in 
psychotic and schizophrenic patients, it has, until now, not been 
shown whether hallucinogenic compounds are endogenously formed, 
which could account for ~he psychiatric symptoms of these pa-
tients. In order to test the hypothesis that this type of com-
pound can be formed during acute episodic psychosis of the manic 
psychedelic type, beta-carbolines and tetrahydro-beta-carbolines 
were measured in blood samples of patients, suffering from acute 
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psychosis on the moment of blood withdrawal. 
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SERINE AND GLYCINE-INDUCED CATALEPSY IN PORPHYRIC RATS; 
AN ANIMAL MODEL FOR PSYCHOSIS? 
published in Pharmacology, Biochemistry & Behaviour 19: 245-250, 
1983 
by 
M.J. Schouten, J. Bruinvels, L. Pepplinkhuizen, 
and J.H.P. Wilson. 
Summary 
It was investigated whether an increased demand for glycine, 
as postulated to occur in patients who have suffered from episo-
dic psychoses accompanied by multiple perceptual distortions, 
could evoke psychotic reactions. Catalepsy was used as a measure 
for psychosis, and was observed after injection of serine or 
glycine in porphyric rats. Catalepsy was shown to occur after 
serine as well as glycine administration in 2-allyl-2-isopropyla-
cetamide (AIA) pretreated rats, while in lead + phenobarbital 
pretreated rats only glycine was effective. Administration of AIA 
to rats resulted in a strongly enhanced excretion of porphobili-
nogen (PBG) in urine, while lead + phenobarbital pretreated rats 
showed increased excretion of d-aminolevulinic acid (d-ALA). The 
lead + phenobarbital pretreated animals showed elevated serine 
plasma levels and lowered glycine plasma levels 18 hours after 
injection, while no significant differences in plasma levels of 
these amino acids were found 24 hours after AIA administration. 
In AIA or saline pretreated animals, but not in those pretreated 
with lead + phenobarbital, glycine formation from serine was 
elevated. It is concluded that the present animal model can be 
used to investigate episodic psychoses. 
29 
Chapter II 
INTRODUcriON 
It has been generally accepted that the effects of halluci-
nogens in man bear a large resemblance to the symptoms of an 
acute psychosis. During the past two decades many suggestions 
have been made about the possible endogenous formation of hallu-
cinogenic or even "schizophrenic11 compounds. Osmond and Smythies 
{1952) were the first to postulate that a false methylation of 
catecholamines may form a biological basis for schizophrenia. 
It has been suggested previously that an increased produc-
tion of methylenetetrahydrofolic acid (CH2=FH4) and not methylte-
trahydrofolic acid (CH 3-FH 4) could be involved in the development 
of schizophrenia (Bruinvels, 1975). Under physiological condi-
tions this compound can be non-enzymatically decomposed into FH 4 
and formaldehyde (HCHO, Donaldson and Keresztesy, 1961) of which 
the latter can react spontaneously via the Pictet-Spengler reac-
tion with indolamines or catecholamines forming THBC's or THIQ's 
respectively {Airaksinen and Kari, 1981 I; Deitrich and Erwi~, 
1980; McMurtrey et aL, 1977). This suggestion was supported by 
the findings of Pearson and Turner (1979) that, in vitro, serine 
hydroxymethyl transferase (SHMT) is capable of forming THBC from 
tryptamine. This enzyme converts serine into glycine and concomi-
tantly, tetrahydrofolic acid (FH4) into CH2=FH4- As has been 
postulated recently, an overproduction of CH2=FH4, caused by an 
increased demethylation of serine, could evoke a schizo-affec-
tive, mescaline-like psychosis. This type of acute psychosis is 
characterized at the onset by multiple sensory perceptual distor-
tions, hallucinations, affective symptoms and finally culminating 
into catatonic states. The typical hallucinogenic drug-like symp-
toms could be evoked by oral administration of serine and in a 
few cases by glycine in a dose of 2 mmol/kg or by the consumption 
of food containing large amounts of serine and glycine. In 20 % 
of these patients also porphyria was detected. This supports our 
hypothesis, since the high demand for glycine during a porphyric 
attack will be met by demethylation of serine by the action of 
SHMT (Pepplinkhuizen et aL, 1980; Bruinvels et aL, 1 980). As 
pointed out above, the concomitantly formed CH2=FH 4 could be 
responsible for the production of tetrahydro-beta-carbolines 
(THBC) or tetrahydroisoquinolines (THIQ) via the Pictet-Spengler 
reaction. 
The present study was undertaken to investigate the possibi-
lity of an animal model in order to obtain more information about 
the postulate that an increased production of CH2=FH 4 during 
increased conversion of serine into glycine, may be responsible 
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for the induction of psychosis. 
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METHODS 
A total number of 54 male albino Wistar rats (125-150 g) was 
used in the present study. Per experiment rats were divided into 
3 groups of three rats. Six experiments were performed. Rats were 
starved for 24 h before the injection of the porphyrinogenic 
agents. 
Induction of porphyria. One group of three rats was injected 
with 25 mg/kg (i.v.) lead acetate (Merck) dissolved in 0.25 ml 
glass-distilled demineralized water (demidest) and 50 mg/kg 
(i.p.) phenobarbital-sodium salt (Gist-Brocades) in 0.5 ml 0.9% 
NaCl (Maxwell and Meyer, 1976). A second group of three rats was 
injected with 400 mg/kg allylisopropylacetamide (AIA, s.c., a 
gift from Hoffman LaRoche; Marver et al., 1966) dissolved in 1 
ml polyethylene glycol (J.T. Baker Chemicals). A control group of 
three rats received polyethylene glycol. The rats were placed in 
metabolic cages (Acme Metal Products, Chic., Ill., USA) immedia-
tely after injection of the porphyrinogenic agents for separate 
collection of urine and faeces. 
Administration of serine or glycine. At maximum porphyria, 
which was 18 h after injection of lead + phenobarbital (Maxwell 
and Meyer, 1976) and 24 h after injection of AIA (Marver et al., 
1966) one rat in each group received serine, glycine (both from 
Aldrich, 2 mmol/kg in 0.5 ml 0.9% NaCl) or saline, respectively 
( i.p.)-
Catalepsy. Catalepsy was measured once before injection of 
serine, glycine or saline, and at 5, 10, 20, 30 and 60 minutes 
after injection of the amino acid. The catalepsy measurements 
were performed by placing the rat on a vertical grit with a grit 
size of 1.5 x 1 em, about 10 em above the cage floor. The time 
the animal did not displace one of his front- or hind paws out of 
this position was recorded. Catalepsy was scored as follows; 
time (sec) 
0 
0-10 
1 0-20 
20-30 
>30 
score 
0 
1 
2 
3 
4 
To detect statistical differences Students' t-test was per-
formed using the total scores of each rat representing the sum of 
catalepsy scores measured in duplo at 5, 10, 20, 30 and 60 mi-
nutes after injection of amino acid. 
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Excretion of d-ALA and PBG in the urine. delta-
Aminolevulinic acid (d-ALA) and porphobilinigen (PEG) in the 
urine were determined according to Doss and Schmidt (1971) with 
some modifications. Urine was collected in dark brown collection 
bottles which were acidified in advance with 100 ul 100% acetic 
acid in order to keep the urine at a pH below 4.7. For determina-
tion of d-ALA and PBG (both from Sigma Chemical Co.), 3 x 0.5 em 
ion-exchange columns were used. To extract d-ALA from the urine, 
0.55 g cationexchange material (Ag 50 WX4 100-200 mesh, H+-form, 
Bio-Rad) was used. PBG was extracted with 0.55 g anionexchanger 
(Ag 1X8 100-200 mesh, acetate form, Bio-Rad). The columns were 
rinsed with 10 ml deionized water before use. The thawed urine 
samples were adjusted between pH 6.0 and 6.5 with solid NaHC03 just before 0.5 ml of urine was loaded onto each column. The 
columns were rinsed with 3x10 ml deionized water, and PBG was 
eluted with 2x2 ml 1M acetic acid, while d-ALA was eluted with 
5 + 2 ml 1M Na-acetate. 0.2 ml acetylaceton (Merck) was added to 
the d-ALA eluates which were incubated for 10 min at 100°C to 
convert d-ALA into a pyrrolic compound. To detect the pyrrolic 
compounds 2 ml of each PBG column eluate or each d-ALA incubate 
was mixed with 2 ml Ehrlich's reagent (100 ml 2.4% (w/v) p-
dimethylaminobenzaldehyde in 100% acetic acid mixed with 
19 ml 70% HCl04 ). This mixture was incubated for 15 min at 37°C 
and extinction was measured at 553 nm. 
Determination of serine and glycine plasma levels. Blood 
samples were taken every 2 min before measurement of catalepsy by 
cutting a small slice from the tail. 50 ul of blood was taken 
into heparinized capillaries. The capillaries were centrifuged 
for 11 min at 12000 rpm (15000xg) in a Haemofuge (Heraeus). 
Plasma was separated by cutting the capillaries just above the 
layer of erythrocytes and transferred on a piece of Parafilm and 
diluted with 4 volumes of elution buffer A as used in HPLC (see 
below). This mixture was incubated at 4°C for 60 min and solid 
particles were spun down in a Beckman Microfuge for 5 min at 
9000xg. Subsequently 10 ul of supernatant was injected into a 
Hewlett Packard Liquid Chromatograph 1084 B equipped with a 20 em 
LiChrosorb RP-8 (5 urn) column (Hewlett Packard). Serine and gly-
cine were determined by using a "Dynamic Ion Exchange" system 
(Kraak et al., 1977) with some modifications: Eluens A consisted 
of 0.5% sodiumdodecyl sulphate (SDS, Merck, w/v) 0.5 mM sodiumci-
trate, 0.3% t-amylalcohol (v/v) and was adjusted at pH 3.20 with 
citric acid. Eluens B consisted of 0.5% SDS (w/v), 10 mM Na3Po4 , 
0.3% t-amylalcohol (v/v) and was adjusted to pH 7.9 with H3P04 . 
Serine and glycine were eluted with buffer A at a flow rate of 
2.4 ml/min at 40°C, followed by 4 min buffer Band 10 min buffer 
A at the same flow rate and temperature to elute the slower 
compounds and those not of interest and to equilibrate the column 
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for the next analysis, respectively. The amino acids were detec-
ted by postcolumn derivatizatio~ with o-phthaldialdehyde (OPA, 
Merck) at ambient temperature using a mixing chamber connected to 
the end of the analytical column. A Duramat Dosing pump (Chemie & 
Filter GmbH, Verfahrenstechnik K.G., Heidelberg 1 ), which was set 
at a flow rate of 2.4 ml/min was used to pump the OPA-reagent 
into the mixing chamber. Fluorescence was measured 3 sec after-
wards in an Aminco SPF 500 ratio fluorimeter using an excitation 
wavelength of 337 nm {bandwith 10 nm) and an emission wavelength 
of 452 nm (bandwith 40 nm). The OPA-reagent was prepared by 
dissolving 0.5 g OPA in 10 ml ethanol and mixing with 2 ml 2-
mercaptoethanol (sol. I). 1 l 3% H3Po4 (w/v) was adjusted to 
pH 10.2 with NaOH pellets (sol. II; Cronin, et al., 1979). Sol I 
and sol. II were mixed and kept under nitrogen in dark brown 
bottles. Under these conditions, the reagent was stable for two 
weeks (Cronin, et al., 1979). 
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RESULTS 
Porphyria. The induction o= porphyria was shown by measuring 
the excretion of d-arninolevulinic acid (d-ALA) and porphobilino-
gen (PBG) in the urine. In rats made porphyric by the injection 
of lead + phenobarbital d-ALA excretion per 48 h was about 
28x increased as compared to the excretion by non-porphyric con-
trol rats, while PEG excretion per 48 hr in these rats was twice 
the amount of control rats. The AIA pretreated rats showed an 
opposite pattern: PBG excretion in these animals was about 
35x the amount excreted by non-porphyric controls, while d-ALA 
excretion was increased by a factor 4 as compared to controls 
(Fig. 1). 
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Fig. 1. Excretion of d-arninolevulinic acid (d-ALA) and porphobi-
linogen (PEG) in the urine during 48 hr after injection of lead + 
Qhenobarbi tal or ATA. 
~<0.001 
P<O.OOS (Student t-test). 
As shown in Fig. 2, blood serine and glycine levels were 
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changed in lead + phenobarbital pretreated rats. Plasma serine 
levels were significantly elevated 18 h after injection of lead+ 
phenobarbital, while glycine levels were significantly lowered. 
No significant differences in plasma serine and glycine levels 
were obtained in AIA pretreated animals measured 24 h after 
injection of AIA. 
Serine-levels Glycine-levels 
:+* 
100 r+ r+ 0 o 
o; 
> 
~ rf* 
0 
> 
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Pb Contr. AlA Pb Contr. AlA 
Ph en Ph en 
Fig. 2. Serine and glycine blClCld. plasma levels during t;:Orohyria. 
These ~e'-:'els _were measured 24 hr after injection of AIA and 18 hr 
after lDJectlon of lead + phenobarbital respectively and before 
injection of serine or glycine. ' 
P<O.OOS (Student t-test). Control serine and glycine plasma le-
vels were 404 (2:_ 13) umol/l and 527 (.:':_ 24) umol/1, respectively. 
No changes in urinary excretion of d-ALA and PBG could be 
found as a consequence of serine or glycine administration in 
both porphyric and control rats. 
As shown in Fig. 3, a negative, semilogarithmic correlation 
between d-ALA excretion and plasma glycine levels was found using 
the data obtained from porphyric and control rats before treat-
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ment with serine or glycine. 
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Fig. 3. Semilogaritlunic correlation tetween excretion of d-PLA 
during 48 hr in the urine and glycine blood plasma levels after 
pretreatment, measured 24 hr after injection of AIA (~)or 
saline ( 4t) and 18 hr after injection of lead + phenobarbital 
(~ )_ 
Serine and glycine administrations. Injection of glycine 
into lead + phenobarbital pretreated rats did not increase serine 
plasma levels (Table 1A), while in AIA pretreated animals serine 
levels were elevated 20-60 min after glycine injections as com-
pared to AIA pretreated, saline injected controls. Only at 30 min 
after glycine administration to saline pretreated rats signifi-
cantly elevated serine levels could be found. Comparable results 
were obtained for the conversion of serine into glycine, indica-
ting no detectable conversion in lead + phenobarbital or saline 
pretreated rats but an increased conversion in AIA-pretreated 
rats 20 min after injection of serine (Table 1B). 
Catalepsy scores. Administration of serine or glycine to AIA 
pretreated rats evoked catalepsy after administration of either 
amino acid as shown in Table 2. However, in lead + phenobarbital 
pretreated rats, only administration of glycine caused catalep-
lepsy. No catalepsy was found in rats pretreated with lead + 
phenobarbital or AIA alone, nor could it be shown after adminis-
tration of serine or glycine in non-pretreated rats. Most of the 
cataleptic rats also exhibited widely opened eyelids and stiff-
ness of the tail (Straub tail). 
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inj. Time in min ~ SEM 
pre- anuno 
treatment acid 0 20 30 60 
lead+ serine 1 oo*+ 8.1 175.5 + 4.9 178.2 + 8.3 151 . 7 + 3.8 
phenob. glycine 100 + 8.4 106.1 + 6. 1 104.7 + 6.5 103.5 + 4.2 
100 :;:: 90.5 :;:: 92.0 :;:: 91 .8 :;:: saline 4.2 3.0 2.7 3.7 
serine 100 + 8.6 207.3 + 11.0 190.2 + 6.5 160.4 + 4.4 
AIA glycine 100 + 7.9 103.5"+ 2.0 103.1"+ 3.6 98.6"+ 3.8 
saline 100 :;:: 3.7 90.9:;:: 2.6 85.0 :;:: 3.0 82.6 :;:: 2.8 
serine 1 00 + 11 . 5 187.0 + 13.7 183.2 + 15.1 156.1 + 11.2 
saline glycine 100 + 4.2 100.9 + 5.1 101.611+ 4.1 93.5 + 5.1 
saline 100 :;:: 5.4 93.7:;:: 1.9 89.8 :;:: 2.1 86.8 :;:: 2.1 
Table 1A. Serine levels in porphyric rats injected with serine or 
\!lycine. 
Mean as percent of control level ( + S.E.M.) of 6 rats. 
$ p<0.01 (Student t-test, amino acid iil.jected vs. saline injected 
~n the same pretreated group at indicated time). 
p<0.05. 
inj. Time in min .:t. SEM 
pre- amino 
treatment acid 0 20 30 60 
lead + serine 100*+ 6.3 92.1 :!:. 3.3 96.2 + 3.7 96.3 + 2.7 
phenob. glycine 100+4.3 302.1 + 32.9 303.5 + 30.7 218.9 + 17.9 
100:;::3.7 93.6:;:: 91.7 :;:: 87.0:;:: saline 2.6 1.4 4.1 
serine 100 + 6.9 102. o$+ 3.7 97.2 + 2.3 102.4 + 4.9 
AIA glycine 100 + 8.6 268.4 + 31.9 229.9 + 13.6 193.7 :;:: 6.7 
saline 100 ~ 4.0 96.7:;:: 1.7 93.2 :;:: 1.4 96.1 + 2.0 
serine 100 + 8.2 90.1 + 2.0 95.0 + 3.2 100.7 + 5.2 
saline glycine 100 + 7.2 249.2 + 22.8 239.6 + 14.5 167.8 + 6.2 
38 
saline 100:;:: 4.5 92.5 :;:: 5.2 94.4:;:: 1 • 5 91.9:;:: 2.2 
Table 1B. Glycine levels in porphyric rats injected with serine 
11r glycine. 
Mean as percent of control level (+ S.E.M.) of 6 rats. 
$ p<0.02 (Student t-test, amino acid-injected vs. saline injected 
in the same pretreated group at irrlicated time). 
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inj w amino 
pretreatment acid total scores :tSEM 
lead+ serine 9.3$ + 1 .7 
phenobarbital glr;ine 16. 7** + 1.6 
sa 1ne 11.1 ::!:: 3. 7 
serine 10.0 + 2.8 
saline glycine 10.0 + 1.6 
saline 8.7 + 1. 7 
serine 19.8~ + 1 .0 
AIA glycine 17.0 + 2.6 
saline 9.8 :±: 2.8 
Table 2. Catalepsy scores in porphyric rats. 
$ Mean of total catalepsy scores (representing the scores mea-
sured at 5, 10, 20, 30, and 60 min after amino acid injection) 
~btained from ~ rats. 
p<O.OS and * p<0.02 vs. glycine injected, non-pretreated rats. 
# p<0.01 vs. serine injected, non-pretreated rats. 
Statistical differences were neasured by applying Student's t-
test. 
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DISCUSSION 
To enhance the demand for glycine, porphyria was chemically 
induced in rats, which were starved 1 day before treatment. For 
this purpose, injection of 2-allyl-2-isopropylacetamide (AIA) was 
used as one method and administration of lead + phenobarbital as 
the other (Marver et aL, 1966; Maxwell and Meyer, 1977; Unseld 
and De Matteis, 1978). 
Administration of AIA resulted in massive excretion of PBG 
per 48 h in the urine. AIA quite specifically acts as a porphyri-
nogenic agent by accelerating the breakdown of heme, which is the 
feedback inhibitor of the heme pathway, and heme proteins, there-
by inducing the activity of d-aminolevulinic acid synthetase (d-
ALAS; Marver et al., 1966; Unseld and De Matteis, 1978; Stephens 
et aL, 1978). This enzyme will produce large amounts of d-ALA, 
which is quickly converted into porphobilinogen (PBG, Marver and 
Schmid, 1972). In order to meet this massive production of d-ALA 
glycine synthesis has to be increased since the latter is one of 
the two s~bstrate for d-ALAS. 
Both lead and phenobarbital are slightly porphyrinogenic. 
However, when injected simultaneously, they have a strong poten-
tiating effect (Maxwell and Meyer, 1976). Our results revealed a 
28x increase of d-ALA excretion in the urine during 48 hr, indi-
cating the induction of d-ALAS, which is in agreement with the 
findings of Maxwell and Meyer (1976). 
The present results show that glycine levels are correlated 
with d-ALA excretion into the urine in both types of porphyria 
(Fig. 3), probably because the demand for glycine is enhanced. 
Because most of the glycine pool is synthesized from serine via 
serine hydroxymethyltransferase (SHMT; Nyhan, 1972; Arnstein, 
1954), increased serine levels in lead+ phenobarbital pretreated 
rats are not expected to occur together with the enhanced need 
for glycine in porphyria. Probably SHMT is inhibited by lead, 
which can react with the sulfhydryl groups at the active site of 
SHMT (Moore et al., 1980; Schirch et al., 1980). This would 
explain both the lowered glycine levels and increased serine 
levels in lead + phenobarbital pretreated rats. 
Different types of animal behaviour can be used as an indi-
cation for psychotic behaviour (Maxwell, 1968; Smythies et al., 
1969; Bloom et al., 1972; Fisher, 1975). Among these, catalepsy 
and catatonia are the most frequently used (Maxwell, 1968; Bloom 
et al., 1972; Segal et al.1 1977). Although these terms are often 
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used interchangeable, they have dissimilar behavioural profiles 
and may imply different categories of participating neurotrans-
mitter systems (Costall and Naylor, 1974). The difference between 
the rigid- and non-rigid-type of immobility (catatonia and cata-
lepsy, respectively) is based on the findings obtained with 
opiate-like drugs and the behaviour seen after neuroleptic drug 
treatment. According to Segal et aL ( 1977), the vertical grid 
test, as used in the present study, measures catalepsy. However, 
some of our cataleptic rats also showed stiff tails and wide-
opened eyelids, which is suggestive for catatonia (Segal et aL, 
1977). Therefore, both serine and glycine probably evoked cata-
leptic as well as catatonic behaviour, which may be comparable to 
the catatonic behaviour shown by some of our patients (Pepp-
linkhuizen et aL, 1980). 
The observation that serine, when injected into lead + 
phenobarbital pretreated rats could not evoke catalepsy, while 
glycine did, is in agreement with the proposed inhibition of SHMT 
by lead as discussed above. This would also explain the increased 
glycine plasma levels in lead + phenobarbital pretreated, glycine 
injected animals (Table 1B). 
The finding that glycine can evoke catalepsy would not 
appear to fit in with our hypothesis that the elevated conver-
sion of serine into glycine gives rise to high levels of CH2=FH4. 
However, high amounts of glycine can be metabolized in the gly-
cine cleavage system (GCS) to co2 and NH3, concomitantly forming 
CH2=FH4 from FH 4. As pointed out above, increased levels of 
CH2=FH4 could be intermediates in alkaloid production. 
Tetrahydro-beta-carbolines (THBC) and tetrahydroisoquino-
lines (THIQ) can be formed from indoleamines and catecholamines 
respectively and formaldehyde, formed by decomposition of 
CH2=FH 4. The possibility that formaldehyde-derived biogenic 
amines can act as psychotogenic or "schizophrenic., agents, is 
suggested by many authors (Deitrich and Erwin, 1980; Airaksinen 
and Kari, 1981 I; Sandler et aL, 1973). Especially THBC's, which 
are derived from indoleamines, received much attention, as re-
viewed by Airaksinen and Kari (1981 I and II) and Airaksinen and 
Mikkonen, (1980). 
Studies are in progress to isolate and identify the com-
pounds responsible for inducing catalepsy in rats. These com-
pounds may also be responsible for evoking episodic psychosis in 
patients. 
In conclusion, catalepsy could be evoked during experimental 
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porphyria in rats after injection of serine and glycine, and may 
probably represent a good model for studying a schizophrenic-like 
psychosis as described previously (Pepplinkhuizen et al., 1980; 
Bruinvels et al., 1980). The AIA-induced porphyria seems to be 
more suitable for further experimentation, because this drug acts 
in a more specific way on the heme pathway. 
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HIGH PERFORMANCE LIQUID CHROMATOGRAPHY OF TETRAHYDRO-BETA-CARBO-
LINES EXTRACI'ED FROM PLASMA AND PLATELETS 
published in Analytical Biochemistry 147: 401-409, 1985. 
by 
M. J. Schouten and J_ Bruinvels. 
Summary 
A fast method for extraction and concentration of tryptamine 
(TA), 5-hydroxy-TA and 5-methoxy-TA was developed using reverse 
phase C-18 sample preparation columns in combination with an ion-
pairing reagent. Using this method, 1,2,3,4-tetrahydro-beta-
carboline (THBC), 6-hydroxy-THBC and 6-methoxy-THBC, the respec-
tive reaction products formed after reaction of formaldehyde with 
the primary amines mentioned above, and beta-carboline (BC, nor-
harman) and 1-methyl-beta-carboline (1-Me-BC, harman) could be 
extracted from human and rat platelets and platelet poor plasma 
(PPP). A HPLC method combined with fluorometric detection was 
developed for the quantitative determination of these compounds 
in the picomole range. The formation of beta-carbolines during 
the extraction procedure was below the limit of detection of the 
assay procedure. 6-0H-THBC, THBC, 1-Me-BC and 5-HT were identi-
fied as normal constituents of human platelets, whereas only 5-HT 
and 6-0H-THBC could be identified in human PPP. In rat platelets 
and PPP 5-HT, but no THBC's could be detected. 
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INTRODUCriON 
During the last two decades interest has arisen in the 
hypothesi-s that endogenously formed 1,2,3,4-tetrahydrO-beta-
carbolines (THBC's) could contribute to psychotic events observed 
in alcoholism or in schizophrenia (Bruinvels et al., 1980; Airak-
sinen and Kari, 1981b; Deitrich and Erwin, 1980; Schouten et al., 
1983; Pepplinkhuizen et al., 1980). Several methods have been 
developed for the determination of beta-carboline compounds in 
brain, adrenal gland, blood platelets and plasma (Eosin et al., 
1983; Rommelspacher et al., 1982; Becket al., 1982b; Barker, 
1982; Faull et al., 1982; Kari et al., 1979; Airaksinen and Kari, 
1981 I). However, some doubt still exists to their physiological 
occurance (Eosin et al., 1983, Bloom and Barchas, 1982), because 
these compounds are very easily formed in vitro under physiologi-
cal conditions from endogenous tryptamines reacting with formal-
dehyde or with acetaldehyde by the Pictet-Spengler condensation 
(Whaley and Govindachari, 1951). Recently, Eosin et al. (1983) 
demonstrated that THBC's could be formed during sample prepara-
tion from formaldehyde present in the organic solvents used in 
the extraction procedure. 
The aim of the present paper was to develop a new method 
using reverse phase C-18 sample preparation cartridges for sample 
preparation together with an ion-pairing reagent in order to 
minimize the use of organic solvents, thus preventing the arti-
factual formation of THBC compounds. The optimal conditions for 
extraction of THBC' s and their monoamine precursors from human 
and rat plasma and from platelets, as well as the absence of the 
artifactual formation of THBC's are described. A new HPLC method 
was developed to separate and quantify the extracted compounds. 
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MATERIALS AND METHODS 
Materials. 5-hydroxy-tryptamine.HCl (5-HT.HCl) and 1-methyl-
beta-carboline (1-Me-BC, harman) were obtained from Sigma Chemi-
cal Co., 5-methoxy-tryptarnine.HCl (5-MeO-TA.HCl) from Aldrich, 
and tryptamine.HCl (TA, purum) and beta-carboline (BC, norharman) 
from Fluka. The organic solvents were obtained from Merck and 
were of Uvasol quality. 1 ,2,3,4-Tetrahydro-beta-carboline (THBC), 
6-hydroxy-THBC and 6-methoxy-THBC were synthesized according to 
the method described by Vejdelek et al. (1961). Reverse phase 
Sep-pak C-18 cartridges were obtained from Waters Ass .. Zorbax 
BP TM C8 was purchased from Chrompack (The Netherlands). Sodium 
cetyl sulphate (SOS) was obtained from Merck. Demineralized dis-
tilled water (demidest) was used as a solvent. 
Sample treatment. Venous blood (30 ml samples) was collected 
in the morning from 5 healthy volunteers (4 males - 1 female; age 
range 24-32 years) in 10 ml Vacutainer Thrombotect tubes contai-
ning 2.5% EDTA, 0.025% 2-chloroadenosine and 7.0% procaine-HCl, 
to inhibit platelet aggregation. Platelet rich plasma (PRP, 15 
ml) was obtained by centrifuging the samples for 20 min. at 
130xg, followed by two 1 0 min. runs at 450xg and 1 400xg ( 20°C), 
respectively, and pooling the supernatants. Platelets and plate-
let poor plasma (PPP) were separated by centrifuging the PRP for 
10 min. at 1 OOOOxg and 1 0°C. 
Rat blood samples (10 ml) were collected from 3 male Wistar 
rats (275- 300 g) by heart puncture (under light ether anesthe-
sia) using a 0.7 x 32 syringe needle which was heparinized to 
prevent blood clotting. To obtain the PRP, these samples were 
centrifuged for 20 min. at 200xg and 20°C followed by two 15 min. 
runs at 600xg and 1400xg1 respectively (both at 20°C). The pooled 
supernatants (PRP, 5ml) were centrifuged for 10 min. at 1 OOOOxg 
and 10°C to obtain platelets and PPP. The number of platelets/li-
ter PRP was determined by electronic counting in a Coulter Coun-
ter Model ZF. 
Extraction procedure. The extraction efficiency of the C-18 
cartridges was optimal at an elution flow rate of 2 ml/min. An 
Ismatec MP-25 25-channel peristaltic pump connected with 20 ml 
syringes which were fitted upon the C-18 cartridges, was used to 
compress the air above the samples admitted to the cartridges, in 
order to obtain reproducible flow rates. The cartridges were 
rinsed with 5 ml methanol, followed by 5 ml demineralized 1 glass-
distilled water (demidest) 1 and finally with 5 ml extraction 
buffer. This buffer contained 60 mM NaH2Po4.2H20, 0.1 mM EDTA (di 
Na-salt) 1 5 mM semicarbazide 1 0.5 mM ascorbic acid and 0.8 M 
NaCl04 and was adjusted to pH 4.0. with H3Po4• Ten ml extraction 
buffer was added to the platelet pellets (see Sample treatment) 
45 
Chapter III 
which were sonicated using a MSE 150 watt ultrasonic desintegra-
tor (20 KHz) for 30 sec at 20 micron amplitude. Remaining mem-
brane fractions were spun down for 10 min. at 1 OOOOxg and 20°C, 
and the supernatant was loaded onto the Sep-pak cartridge. One 
volume of Sx concentrated extraction buffer was added to 4 volu-
mes of platelet poor plasma (PPP, see Sample treatment) and 
loaded onto the cartridges. The cartridges were rinsed with 
another 5 ml extraction buffer and eluted with 3 ml methanol. The 
extracts were concentrated by evaporation in a Rotavapor (Buchi), 
and the residue was taken up in 1.0 ml 25 mM (NH4 )2HP0 4 buffer (pH 4.0) containing 10 mM sodium octylsulphate (SOS), 0.5 mM 
EDTA, 25 mM semicarbazide and 2.5 roM ascorbic acid. 
Recoveries from the Sep-Pak columns were determined by car-
rying out the described extraction procedure using 10 ml extrac-
tion buffer containing 5 nmol of each compound (Fig. 3). Recove-
ries from PRP and platelet pellets were determinded according to 
the same procedure, using the sample volumes as described in the 
preceding section. 
Chromatographic procedure. High performance liquid chromato-
graphy was performed on a HP 1084 B Liquid Chromatograph (Hewlett 
Packard) using a stainless steel column (250 x 4.6 rom) home-
packed with Zorbax BP TM C8 (7-8 micrometer; Chrompack). A 
Chrompack 75 x 2.1 mm Guard Column was used to protect the analy-
tical column. The flow was kept at 2 ml/min at a temperature of 
45°C. 
System I. With this chromatographic system 6 aromatic amines 
could be separated: Tryptamine (TA), 5-hydroxy-TA (5-HT), 5-
methoxy-TA (5-MeO-TA), 1 ,2,3,4-tetrahydro-beta-carboline (THBC), 
6-Hydroxy-THBC (6-0H-THBC) and 6-methoxy-THBC (6-MeO-THBC). Buf-
fer A, containing 1 mM SOS, 25 mM (NH4)2HP04 and 0.5 % 2-propanol (Merck, Uvasol), was dissolved in demidest, adjusted to pH 8.0 
and filtered through a 0.45 micrometer HA filter (Millipore). 
Buffer B, consisting of 1 mM SOS, 50 mM (NH 4 ) 2HP0 4 , and 25 "' 2-
propanol was adjusted to pH 6.0 and filtered through a 0.5 micro-
meter FH filter. A gradient system was used as depicted in Fig. 
1. Injectionvolume was 200 microliter. The compounds were detec-
ted by using an Aminco SPF 500 ratio fluorometer fitted with a 35 
microliter flow cell. Excitation wavelength was 290 nm (bandwith 
15 nm) and emission wavelength was 335 nm (bandwith 40 nm). 
System II. With this system beta-carboline (BC, norharman) 
and 1-methyl-BC (1-Me-BC, harman) could be separated. Chromato-
graphy was performed with a single buffer system containing 25 mM 
(NH 4 l 2HP0 4 and 30 % 2-propanol in demidest. The pH was adjusted 
to pH 6.0. Injection volume, buffer flow rate and column tempera-
ture were the same as described above. However, no gradient 
system was needed to separate BC and 1-Me-BC. In this system 
detection was performed by measuring the fluorescence using an 
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excitation wavelength of 375 nm (bandwith 15 nm) and an emission 
wavelength of 434 nm (bandwith 40 nm). 
Quantitation. Quantitation of the eluted peaks was performed 
by automatic peak area integration using the Hewlett Packard 
79850B terminal. When quantitating small peaksr the use of the 
integrator is limited by the lowest detectable slope increase in 
relation to the baseline noise. Under these circumstances we used 
peak height as a measure for the concentration of 6-0H-THBC, THBC 
and 1-Me-BC, isolated from platelets or plasma. The latter method 
proved to be more accurate then electronic integration for peak 
heights ranging from 3-15x baseline noise. The precision of this 
method depended on the peak height measured, and ranged from 89% 
(peak height 3x baseline noise) to 98% (peak height 15x baseline 
noise). Quantitation was performed using external standards. 
Retention times were automatically printed in hundreds of minutes. 
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RESULTS 
Chromatography. HPLC-separation of a mixture of beta-carbo-
lines and their precursors using a Na2HP04 buffered system with-
out the addition of an ion-pairing reagent resulted in bad sepa-
rations of the indole- and beta-carboline compounds and broad, 
tailing peaks {Fig.1 A). Addition of the ion-pairing reagent so-
dium octylsulphate (SOS) to a Na 2 HP0 4 buffered chromatographic 
system significantly increased retention times, while peak shapes 
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Fig. 1 • HPLC of indolearnine and beta-carOOline compounds. Flow: 2 
ml/rnin.; Temp. 450C.; 1A: Standard sample (200 pmol/compound). 
Buffer A: 25 mM Na2HP04, 0.5 % 2-propanol, pH 8.0; buffer B: 25 
mM Na2HP04, 25 % 2-propanol, pH 6.0; 1B: Standard sample; buffers 
as in Flg 1A, with the addition of 1 rnM sodium octylsulphate 
(SOS) in both buffers; 1C: Standard sample; System I (see Me-
thcds); Fig 10: Human platelet sample, system I. 
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greatly improved (Fig. 1B). Replacement of Na+ by NH 4+-ions (=System I; Fig. 1C) resulted in a further improvement of peak 
shapes {System I). A pH- and propanol gradient was necessary to 
optimize the separation of these compounds. Buffer A, adjusted to 
pH 8.0 proved to be optimal for the separation of 5-HT and 6-0H-
THBC, whereas buffer B, adjusted to pH 6.0 was optimal for sepa-
ration of the other four aromatic amines. Under these conditions 
neither BC nor 1-Me-BC were detectable, as a result of different 
chromatographic and fluorometric properties (see description 
System II). 
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inj. 2 4 6 8 10 min inj. 2 4 6 8 10 min 
Fig. 2. HPLC of BC and 1-Me-BC. (System II, see methods) Flow: 2 
ml/min; Temp. 45oc. 2A: Human platelet extract; 2B: Standard 
sample, 200 pmol/ compound. 
Separation of 1-Me-BC and BC could be partly achieved by 
using a single buffer system (system II, pH 6.0) on the same 
column (Fig. 2A). For optimal separation of these two compounds 
the pH had to be adjusted to 6.0. Addition of SOS to System II 
resulted in bad separations and increased retention times (chro-
matogram not shown). Under these conditions none of the THBC's 
and indoles, as measured in System I, were detectable. 
Extraction. Increasing concentrations of NaClo4 in the ex-
traction buffer, using the Sep-Pak C-18 extraction procedure 
significantly improved recovery of 5-HT and 6-0H-THBC (Fig. 3A), 
while the optimal pH for extraction ranged from 4.0 to 6.0 (Fig. 
3B). The lower pH limit (pH 4.0) was chosen in the standard 
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procedure in order to minimize in vitro formation of beta-carbo-
line compounds (Whaley and Govindachari, 1951). Under these con-
ditions extraction recoveries of 5 nmol 1-Me-BC and 5 nmol BC 
were 93 % and 97 %, respectively. In the presence of platelets or 
PPP recoveries were from 75% for the more hydrophilic compounds 
(5-HT and 6-0H-THBC) and 94% for the more lipophilic compounds 
(5-MeO-TA, TA, 6-MeO-THBC, THBC, BC and 1-Me-BC). 
Q.l 0." 0.6 
:N~CI o"]IMI 
Fig. 3 A: %Extraction vs. [NaCl04] (pH= 5.0). B: %Extraction 
vs. pH ([NaCl04J= 0.6 M). O-c>S-HT;<>-<>6-0H-THBC; o-cS-MeO-TA; 
•-~TA; .A -A 6-MeO-THBC; !R· • THBC. These experiments were performed 
us1ng 5 nmol of each compound tested. Further conditions as 
described in Materials and Methods. 
Formation of beta-carbolines during extraction procedure. 
Artifactual formation of THBC compounds was checked by spiking 
platelet and PPP samples with 5 nmol TA, 5-MeO-TA and 5-HT, 
respectively. After these samples had gone through the entire 
procedure artifactual formation of THBC's was below limits of 
detection (see Table 1). However, when semicarbazide was omitted 
from the extraction buffer or from the extracted samples prior to 
HPLC analysis, artifactual formation of 6-MeO-THBC from 5 nmol 5-
MeO-TA /5 ml PPP could be detected in rat PPP samples (9 pmol 6-
MeO-THBC/ml extract). Formation of 6-0H-THBC or THBC from 5 nmol 
5-HT or TA, respectively, was below the limits of detection. 
Beta-carboline and indolearnine levels in plasma and 
platelets. Chromatograms of human platelet extracts using system 
I and II are shown in Fig. 1D and 2A, respectively. 5-HT, but no 
beta-carbolines could be detected in rat plasma and platelets 
(Table 1). 6-0H-THBC, THBC, 1-Me-BC and 5-HT could be detected in 
human platelets, whilst only 6-0H-THBC and 5-HT were found in 
human PPP (Table 1). TA and 5-MeO-TA levels in human and rat 
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platelets were less than 0.4 and 0.2 pmol/1 08 platelets, respec-
tively. Human PRP contained 249 ~ 40 x109 platelets/1 PRP, 
whereas rat PRP contained 1320 .=_ 123 x1 0 9 platelets/1 PRP. The 
total number of platelets in the pellets obtained from 15 ml 
human PRP and 5 ml rat PRP, were 3.7 + 0.6 x10 9 and 6.6..!. 0.7 
x109 platelets, respectively. 
platelets (prol/1 os :!:. SEMJ ppp (prol/ml :!:_ SEM) 
ccrnpound RAT* HUMl\N + RAT# HUMl\N $ 
5-HT 627 + 45 330 + 54 625 + 44 160 + 9 
6-0H-THBC <0.8 5.3 -+ 1.1 <4.6 7.4 + 0.4 
6-MeO-THBC <0.2 <0.2 <2.0 <0.7-
THBC <0.4 2.3 + 0.3 <4.3 <1.4 
1-Me-BC <0.04 0.26 _:;: 0.05 <0.5 <0.3 
BC <0.07 <0- 1 <0.5 <0.3 
Table 1. 5-HT and beta-carbolines in man and rat. The following 
~mounts .of sample were used: 
6.6*10~ rat platelets/samplei 
+ 3.7*109 human platelets/sample; 
# 5 ml rat PPP/sample; 
$ 1 5 ml human PPP I sample. Data were not corrected. for recovery. 
retention times (min. _,;t S.D.) 
ppp platelets 
standard not spiked spiked not spiked spiked 
6-0H-THBC 
THBC 
1-Me-BC 
11.63 + 0.08 
16.38 + 0.08 
5.86 _:;: 0.11 
11 - 69 * 
n.d. 
n.d. 
11 -65 
16.33 
5.86 :!:_ 0.16 
11 -60 
16.38 
n.s. 
Table 2. HPLC retention times of beta -carbolines in human PPP and 
platelet extracts before and after spiking. Samples were spiked 
with approximately the same amount of 6-0H-THBC or THBC as found 
in the samples before spiking. J-Me-BC was not spiked, but reten-
tion times of 1-Me-BC peaks in human platelet extract chromato-
wams were compared with standard retention times. 
n.d.=not detected. 
# n.s.=not spiked. 
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To confirm the identity of the beta-carboline compounds 
measured in plasma and platelets, some human samples were spiked 
with 6-0H-THBC and THBC (Table 2). The retention times of the 
detected beta-carbolines in PPP and platelet samples were within 
the error range of standard retection times (Table 2). 
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DISCUSSION 
Several techniques have been applied to the separation and 
quantification of beta-carboline derivatives, e.g. high perfor-
mance liquid chromatography (HPLC) in combination with amperome-
try (Rommelspacher et al., 1982), thin layer chromatography (TLC) 
in combination with fluorometry (Rommelspacher et aL, 1982) or 
(3H)-acetic anhydride labeling (Rommelspacher et aL, 1 979) and, 
most frequently, gas chromatography (GC) in combination with mass 
spectrometry (MS, Basin et aL, 1983; Becket al., 1982 a and b; 
Barker, 1982; Faull et al., 1982; Kari et al., 1979). This topic 
has been extensively reviewed by Airaksinen and Kari (1981 I). 
The GC/MS technique involves derivatization of the beta-carboline 
compounds with pentafluoropropionyl (PFP) or heptafluorobutyryl 
(HFB), in order to make the beta-carbolines more volatile. If 
trace amounts of formaldehyde are present during these derivati-
zation reactions, the condensation reaction between formaldehyde 
and biogenic amines could easily take place. Another disadvantage 
of the GC technique in trace analyses involves the need to 
saturate the GC column with these derivatives prior to quantifi-
cation of the beta-carboline compounds (Faull et al., 1982). To 
avoid these problems we investigated the possibility analyzing 
underivatized beta-carbolines using the HPLC technique. 
Chromatography of alkaloid compounds using reverse phase 
packing materials results in tailing peaks (Fig. 1A and 1B), 
probably due to the interaction of the aromatic amines with non-
silanized Si-OH groups at the packing surface which disturbs the 
reverse phase separation process (Sokolowski and Wahlund, 1980). 
These interactions can be prevented by using "end-capped" packing 
materials, or addition of alkylammonium ions, in order to reduce 
peak tailing (Sokolowski and Wahlund, 1980). Ammonia was used to 
shield residual Si-OH groups from interaction with the alkaloid 
components in the mobile phase. 
The addition of sodium cetyl sulphate (SOS), also improved 
peak shape, which may be ascribed to the ionic interaction ("ion-
pairing") between SOS and the aromatic amines which prevents the 
latter from reacting with free Si-OH groups (Olieman et al., 
1977). Separation of 1-Me-BC and BC did not improve after addi-
tion of sos_ 
In order to obtain detectable amounts of beta-carbolines 
using the present chromatographic system, concentration and 
clean-up of the samples was necessary. Initial experiments using 
XAD-2 resin (300-1000 micrometer), 50 WX 8 cation exchange resin 
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and Sep-pak C-18 reverse phase cartridges showed the latter to be 
superior in loading capacity. Because small volumes are needed 
for quantitative elution of the beta-carbolines, only small 
amounts of organic solvent are required in this procedure. How-
ever, 5-HT and 6-0H-THBC, the more hydrophylic aromatic amines, 
had lower extraction recoveries (28 % and 36 % respectively) due 
to a lower affinity of these compounds for the Sep-Pak columns 
(Fig. 3A). The higher extraction recoveries for these compounds 
using the same columns, reported by Faull et al. (1982), were 
probably due to the use of smaller sample volumes and smaller 
volumes for flushing and elution. 
Addition of NaCl0 4 as an ion-pairing reagent dramatically 
increased the extraction recoveries of 5-HT and 6-0H-THBC (Fig. 
3A), whereas the recoveries of the other beta-carbolines remained 
unaffected. Using this method, it is possible to precipitate 
proteins with 0.4 - 0.6 M HC10 4 prior to the extraction proce-
dure, although this is not a nessecary step to obtain satisfacto-
ry extraction recoveries from plasma or platelets. 
The optimal pH during extraction ranged from 4.0 to 6.0 
(Fig. 3B). because beta-carbolines are more easily formed from 
indolamines and formaldehyde at alkaline pH (Whaley and Govinda-
chari, 1951 ), the use of lower pH values (pH 4.0) during extrac-
tion reduced the possibility of art if actual formation of these 
compounds. However, the use of' a formaldehyde trapping agent 
remained necessary. The formation of a small amount of 6-MeO-THBC 
in rat PPP when semicarbazide was omitted from the extraction 
buffer in the presence of 5-HT, 5-MeO-TA and TA indicates that 5-
MeO-TA reacts more readily with formaldehyde than 5-HT or TA. 
These results are in accordance with the findings by Eosin et al. 
(1983). Spiking platelet suspensions or platelet poor plasma 
(PPP) with 5 nmol 5-MeO-TA in the presence of semicarbazide did 
not result in artifactual formation of 6-MeO-THBC. It seemes 
unlikely therefore that the 6-0H-THBC detected in human platelets 
had been formed from 5-HT during work-up, especially since 5-HT 
reacts more slowly with formaldehyde than 5-MeO-TA. 
Retention times of the beta-carbolines extracted from plasma 
and platelets were within the range of retention times of stan-
dard compounds. In order to confirm the identity of the measured 
peaks some of these extracts were spiked with a small amount of 
standard beta-carbolines, and then reanalyzed on HPLC. Beta-
carboline retention times after spiking corresponded with reten-
tion times before spiking (Table 2), indicating that the measured 
peaks almost certainly represent the indicated beta-carbolines. 
Moreover, fluoresence of the eluted peaks were measured using an 
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excitation wavelength of 290 nm and an emission wavelength of 335 
nm for identification and quantification of THBC's, and 375 nm 
and 434 nm respectively for the unsaturated beta-carbolines. The 
fluorescence measurement, combined with the use of narrow band-
withs (15 and 40 nm for excitation and emission respectively) 
also added to the specificity of the detection. 
We have compared values of beta-carbolines given in this 
paper with those previously published. Rommelspacher et al. 
(1979, 1982) reported that 6-0H-THBC was present in rat and human 
platelets. We have comfirmed this observation using human plate-
lets, but were unable to detect 6-0H-THBC in rat platelets. We 
could not detect 6-MeO-THBC using this technique although Barker 
reported that this compound was present in human platelets (Bar-
ker, 1982). THBC in human platelets was detected by several 
authors at somewhat varying concentrations, but in the same order 
of magnitude as reported in this paper. We were not however, able 
carrpound species locus cone. dimension reference 
5-Hr rat platelets 229b pm/1 o8 Udenfriend 1964 
man platelets 540b 
" 
Rommelsp. 1982 
" " 
74 - 440 
.,;,;ml Girard 1963 
" 
ppp 5.7- 142.9 Crawford 1965 
6-0H-TilBC rat platelets 3.2 - 6.9 pm/108 Rommelsp. 1982 
" " 
275 + 129 Ra:rrnelsp. 1979 
llBil 
" 
2.7 ~ 0.3 
" 
Rommelsp. 1982 
6-MeO-TilBC man 
" 
7.5*,# 
" 
Barker 1982 
TilBC 
" " 
5.8* 
" 
Honecker 1978b 
" 
10.6,.:>:.1.6 
" 
Kari 1979 
" " 
0~5# 
" 
Honecker 1980 
" pl~~ 20 ' ~/ml Barker 1982 
" 
31.4:!:. 5.1 Kari 1979 
1-Me-BC man platelets detected Bidder 1979 
Table 3. Beta-carOOlines in man and rat found by other w~rkers. 
All results from other reJ;OrtS are expressed as pmol/1 0 plate-
J:ets or as pmol/ml PPP, in some cases with standard deviation. 
Data were obtained by recalculation of original data. 
# In this study TilBC (1 0.3 ng/ml) and 6-MeC-TilBC (3.8 ng/mlJ were 
identified in whole blociL The amount of beta-carboline/10 pla-
telets was calculated assuming that 1 ml of whole blocxl contains 
3x108 platelets and all beta-carbolines are concentrated into the 
platelets. 
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to detect THBC in human PPP, as reported by Kari et aL (1979). 
The concentration of 5-HT in human plasma and platelets using our 
method is in agreement with values reported by others (Uden-
friend, 1964). 
The present 5-HT values in rat plasma are quite high. Since 
5-HT in human plasma was in the normal range, these high values 
in rat plasma could have been due to a higher incidence of plate-
let disruption since, in this species, the number of platelets 
per ml is 4x higher than in human PRP, while 5-HT content in rat 
platelets is about the same (Garattini and Valzelli, 1965; Altman 
and Dittmer, 1964). 
In conclusion, the presently described procedure is a fast 
and simple method for extraction, concentration and quantifica-
tion of beta-carboline derivatives and their precursors, although 
additional identification may be necessary by using another more 
selective detection scheme, like mass spectrometry (experiments 
in progress). The values of the beta-carbolines found in blood 
platelets and PPP are in accordance with or less then concentra-
tions reported by others. The failure to detect these substances 
using the present method cannot be due to a lower sensitivity, 
but may rather suggest that they were artifactually formed during 
the isolation and analytical procedures employed by others. 
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ENDOGENOUSLY FORMED NORHARMAN (beta-CARBOLINE) IN PLATELET 
RIC!! PLASMA OBTAINED FROM PORPHYRIC RATS 
Pharmacology, Biochemistry & Behaviour In press, May 1986. 
by 
M. Joris Schouten and Jacques Bruinvels 
Summary 
Porphyria was induced in adult male Wistar rats starved for 
24 hrs by s.c. injection of 400 rng/kg allylisopropylacetamide 
(AIA). The presence of porphyria was shown by measuring excretion 
of delta-aminolevulinic acid (delta-ALA) and porphobilinogen 
(PBG) into the urine during 24 hr after AIA administration. 
Plasma levels of glycine, serine and of a number of other amino 
acids were decreased in porphyric rats as compared to controls. 
Intraperitoneal injection of 2 mmol/kg serine 24 hr after AIA 
administration was used as an animal model for an acute psycho-
sis, by measuring catalepsy scores 30 min after serine injection. 
The concentration of 5 different beta-carbolines in platelet rich 
plasma (PRP) was measured using an HPLC-fluorometric method. An 
increase in the concentration of nor harman (NH) in PRP, ranging 
from 0.57 nmoles/1 in control rats to 1.88 nmoles/1 in serine 
treated porphyric rats was found. The catalepsy duration was 
exponentially correlated with the NH concentrations in PRP. It is 
concluded that an elevated conversion of serine into glycine via 
serine hydroxymethyltransferase (SHMT) may be responsible for the 
enhanced NH biosynthesis. 
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INTRODUCTION 
Initiated by the transmethylation hypothesis of Osmond and 
Smythies (1952), several investigators have postulated the endo-
genous formation of beta-carbolines from indoleamines acting as 
"psychotogens" (Bruinvels and Pepplinkhuizen, 1984; Honecker 
et al., 1980; Kari et al., 1979; Schouten and Bruinvels, 1983). 
However, until now, no increased levels of beta-carbolines in 
schizophrenics could be detected (Rimon et al., 1984). The invol-
vement of beta-carbolines in a group of patients suffering from 
an episodic, schizo-affective psychosis of the manic-psychedelic 
type has been suggested previously. It was shown that within 2-3 
hours after oral administration of serine to clinically recovered 
psychotic patients, psychotic symptoms reappeared (Pepplinkhuizen 
et aL, 1980; Bruinvels et aL, 1980). An increased conversion of 
serine into glycine was proposed to be responsible for the pro-
duction of beta-carbolines, thus evoking psychotic symptoms. 
It has been shown previous:.y that i.p. injection of serine 
into porphyric rats causes catalepsy. This behavioural phenomenon 
was used as an animal model for the acute psychosis studied 
(Schouten and Bruinvels, 1983). According to the hypothesis des-
cribed above,it was proposed that in porphyric rats beta-carbo-
lines could be formed as a result of an increased serine to 
glycine conversion via the enzyme serine hydroxymethyltransferase 
(SHMT). Pearson and Turner (1979) showed that 1,2,3,4-tetrahydro-
beta-carboline (THBC) can be formed in vitro by SHMT if incubated 
with serine in the presence of tryptamine. This finding supports 
our hypothesis that an increased conversion of serine into gly-
cine in vivo could give rise to t~e endogenous formation of beta-
carbolines. 
The aim of the present study was to investigate whether an 
increased formation of beta-carbolines occurred in porphyric rats 
treated with serine, and whether this is related to the catalep-
tic behaviour observed. 
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MATERIALS AND METHODS 
Male Wistar rats (280-320 g) were starved for 48 hr. After 
24 hr the starving rats were injected subcutaneously with 400 
mg/kg allylisopropylacetamide (AIA, a generous gift of Hoffmann-
La Roche, The Netherlands), dissolved in 1 ml polyethyleneglycol 
(PEG), which had an approximate molecular weight of 200 (Baker 
Grade, Baker Chemicals). During the following 24 hr of starvation 
urines were collected in dark brown glass bottles to which 0.1 ml 
glacial acetic acid (Merck) was added before collection of the 
urine, in order to prevent delta-aminolevulinic acid (delta-ALA) 
breakdown. delta-ALA and porphobilinogen (PEG) were determined as 
described previously (Schouten and Bruinvels, 1983). After the 48 
hr starvation period a blood sample of 0.4 ml was taken by heart 
puncture under light ether anaesthesia just before the adminis-
tration of serine, for determination of plasma amino acids. Amino 
acid analysis was performed using an LKB Model 4400 Amino Acid 
Analyzer according to the standard methods for determination of 
free amino acids in blood plasma, as described by Bruinvels and 
Pepplinkhuizen (1984). 
Twenty-four hours after AIA administration rats were injec-
ted intraperitoneally with 2 rnmol/kg serine (Merck, biochemical 
grade) dissolved in 0.5 ml saline, or with the vehicle solely. 
Thirty minutes after serine injection, catalepsy was measured by 
placing the rat on a vertical grid with a grid size of 1.5x1 em, 
about 10 em above the cage floor. The time the animal did not 
displace one of its front- or hind paws was recorded. This measu-
rement was repeated twice and the mean duration was calculated. 
Immediately after the three catalepsy measurements 2 blood sam-
ples (0.4 rnl and 10 ml for plasma amino acid and for beta-
carboline determination, respectively) were collected by heart 
puncture under light ether anaesthesia, and beta-carbolines were 
determined in platelet rich plasma according to the method des-
cribed by Schouten and Bruinvels (1985). 
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RESULTS 
The induction of porphyria was checked by measuring delta-
aminolevulinic acid (delta-ALA) and porphobilinogen (PBG) ex-
creted into 24 hr urine (Table 1). A significant increase in 
delta-ALA excretion, and a massive increase in PBG excretion was 
measured in the AIA pretreated rats, indicating that these rats 
had developed a severe porphyria. 
porphyrin 
delta-ALA 
PEG 
pretreatment 
Controls 
490 + 32 
24.5 I 3.5 
AIA 
898 + 118 
753 I 115 
%Change 
+ 83.2 % 
+ 2970 % 
2P< 
0.005 
0. 001 
Table 1. delta-Aminolewlinic acid (delta-ALA) and porphobilino-
gen (PBG) excretion (nmoles/24 br + SEM) into urine during 24 br 
after s.c. injection of 400 mg/kg-allylisopropylacetamide (AIA). 
Statistical calculations were performed using Students' t-test; 
N=42). 
Determination of plasma amino acids 24 hrs after AlA-pre-
treatment revealed a significant decrease of about half of the 
plasma amino acids (Table 2) The greatest decrease was found for 
glycine (43,9 %), while arginine, tyrosine and serine were de-
creased for about 40 percent. No significant differences in 
plasma concentration were measured for the amino acids not men-
tioned in Table 2. 
The norharman concentration in platelet rich plasma (PRP) 
was signficantly increased after treatment of rats with AIA or 
serine. Although AIA + serine treatment caused a further increase 
of NH concentration, the latter was not significantly different 
from controls due to the large standard error. The concentrations 
of 6-hydroxytetrahydro-beta-carboline (6-0H-THBC), 6-methoxyte-
trahydro-beta-carboline (6-MeO-THBC), tetrahydro-beta-carboline 
(THBC) and 1-methyl-beta-carboline (harman, 1-Me-BC) in PRP were 
below limits of detection. Catalepsy was significantly increased 
after treatment with AIA + serine, as compared to both control 
and AIA treated rats, and after serine treatment when compared to 
control rats. However, rats treated solely with AIA did not show 
any cataleptic behaviour. During the cataleptic episode, catato-
nic phenomena like Straub tail, were also observed (data not 
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shown). 
pretreatment 
amino acid Controls AIA %Change 2P< 
glycine 451 ±.16 253 + 14 - 43.9 % 0-0001 
arginine 134 + 3 80.0 + 4.2 - 40.3 % 0.0001 
tyrosine 95.8 + 2.5 57.5 + 1.8 40.0 % 0.0001 
serine 293 +11 178 + 4.4 39.2 % 0. 0001 
glutamic acid 86.7 + 5.3 53.4 + 6.7 38.4 % 0.0005 
asparagic acid 12.3 + 1.0 7.9 +0.4 35.4 % 0.0005 
ornithine 55.6 + 3.1 38.0 + 2.7 31.6 % 0.0001 
citrulline 50.5 + 1.3 34.9+1.7 30.9 % 0.0001 
alpha-ABA 14.4 + 1.0 10.3 + 1.0 - 28.5 % 0. 01 
alanine 266 +9 194 +11 27-1 % 0.0001 
threonine 212 + 6 156 +5 - 26.4 % 0.0001 
taurine 145.3 + 7.2 110.7 + 5.7 23.8 % 0.0001 
methionine 49.9 + 0.9 42.9+2.1 - 14.0 % 0.002 
histidine 55.9:;: 1.4 49.2 :;: 2.0 - 11.7% 0.01 
Table 2. Plasma amino acids (mM ±. SEM) in starved porphyric rats, 
measured 24 hrs after AIA treatment, just before serine injec-
tions. Statistical calculations were performed using Students' 
paired t-test (N=18). 
treatment catalepsy norha.I:man serine glycine 
Control 3.7+2.1* 0.57 + 0.03 267 + 20 453 + 32 
AIA 4.1 + 1.2 1.08+0.19+ 205 + 20+ 300 + 3Q++ 
Serine - + 1.63 + 0.34+ 778 + 61+++ 409 + 31 13.3 + 4.4 # 
AIA + Serine 24.9:;: 4.2+++, 1.88 :;: 0.85 663 + 3s+++ 319:;: 30++ 
Table 3. Catalepsy duration (sec), NH concentration in platelet 
rich plasma (nM) and serine and glycine plasma concentration (uM) 
in porphyric rats 30 minutes after 2 mmol/kg serine Lp. injec-
tions. Statistical calculations were performed using the Mann-
Whitney-U-test for the catalepsy data and Students' t-test for 
~e other parameters. 
data represent mean + SEM (N=9) . # P<O.OS, ++ P<O.OOS aDd +++ P<0.002 vs. controls. 
P<0.005 vs. AIA. 
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After serine injections, serine plasma levels were 3-fold 
increased when compared to controls and AIA pretreated animals 
(Table 3). Glycine plasma levels were decreased in AIA pretreated 
animals, and did not change significantly after serine adminis-
tration. 
When the duration of catalepsy was plotted against the 
norharman concentration in PRP, these data showed best fitting 
into an exponential curve (Fig. 1). No correlation Was found 
between delta-ALA or PBG excretion and norharman PRP-levels du-
ring porphyria (data not shown). 
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catalepsy (sec) 
30 
0 
20 
10 
D 
01--------.---------.--------.--------,---
0 0.5 1.0 1.5 2.0 
nor harman ( nmoles. J-1) 
Fig. 1. Correlation of norhannan concentration in PRP (nrnoles/1) 
vs. catalepsy duration (sec). Each value represents the mean of 9 
observation pa.irs. Curve fitting on the data in table 3 indicated 
that an exponential fit showed best correlation (R=0.894). 
Legend to figure: $==control; 
D =AIA; 
ll =serine; 
0 ==AIA + serine. 
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DISCUSSION 
Many suggestions have been put forward concerning the endo-
genous formation of beta-carbolines and its relation to a number 
of behavioural disturbances (Bruinvels et al., 1980; Honecker 
et aL, 1980; Kari et aL, 1979; Rimon et al., 1984). Previously, 
an animal model for an acute psychosis has been developed, using 
administration of serine to starved porphyric rats assuming that 
beta-carbolines could be formed endogenously under these circum-
stances (Schouten and Bruinvels, 1983). The present experiments 
were designed in order to show the presence and to measure the 
concentration of 5 different beta-carbolines in serine treated 
porphyric rats using a chromatographic method where the artifac-
tual formation of beta-carbolines was excluded or at least below 
the limit of detection (Schouten and Bruinvels, 1985). 
In the present study, a severe porphyria developed after AIA 
administration to starved rats, resembling acute intermittant 
porphyria (AIP) as indicated by the massive increase of delta-
aminolevulinic acid (delta-ALA) and porphobilinogen (PBG) excre-
tion into urine (Table 1). It has been shown that AIA depletes 
the heme pool by inducing cytochrome P 450 activity, thus causing 
strong induction of the enzyme delta-aminolevulinate synthase 
(delta-ALAS), the first enzyme in the heme pathway, in liver 
{Fig. 2; Marver et al., 1966; Unseld and de Matteis, 1978). As a 
result, the demand for glycine will be increased in these porphy-
ric animals. Indeed it has been shown that plasma glycine levels 
were decreased in porphyric rats, and a negative correlation was 
found between delta-ALA excretion and glycine plasma levels 
(Schouten and Bruinvels, 1983). The present results show that 
plasma levels of serine and threonine were also significantly 
lowered during AlA-porphyria (Table 2), probably because the 
increased amount of glycine needed for porphyrin biosynthesis is 
produced from these amino acids by serine hydroxymethyltransfe-
rase (SHMT). Since the Km values of SHMT for serine and glycine 
are low, the enzyme will be nearly saturated with its substrates 
in vivo. The direction of the equilibrium reaction will therefore 
be determined by the intracellular concentrations of each of the 
substrates (Snell, 1984). In porphyria, where the demand for 
glycine is increased, glycine concentrations were significantly 
lowered and thus more serine must be converted into glycine (see 
Fig. 2). However, in the present experiments serine administra-
tion did not increase glycine plasma levels, and therefore does 
not favour an increased conversion of serine into glycine in both 
porphyric and non-porphyric animals (Table 3). An explanation for 
this failure may be that metabolic pathways which convert glycine 
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cyclization 
ser gly 
+ ---=-5--•o-ALA 
succinyl CoA i- 6 
PBG 
j. 
f 
heme 
Fig. 2. Metab:>lic pathways of the one-carton cycle, serine- and 
glycine metabolism and the heme pathway. 
1. Serine hydroxymethyltransferase (SHMT). 
2. Methylenetetrahydrofolate reductase (CH2-FH4). 
3. Methyltetrahydrofolate: homocysteine methyltransferase. 
4. Non-enzymatic cleavage of CH2-FH4 to FH4 and formaldehyde, 
followed by the Pictet-Spengler reaction. 
5. delta-Aminolevulinic acid synthetase (delta-ALAS) 
6. Poqhobilinogen synthase (PEGS) 
¢-(CH2)2NH2 = indoleamine or catecholamine 
into other products occur too fast in the rat to measure an 
increased formation of glycine in plasma 30 min after serine 
administration in contrast to results obtained in man (Bruinvels 
and Pepplinkhuizen, 1984). 
The expected increased conversion of serine into glycine 
will simultaneously increase the production of CH2-FH4 from te-
trahydrofolate {FH4 , Fig. 2; Bruinvels et al., 1980). Studies of 
Pearson and Turner (1979) showed that THBC's can be synthesized 
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in vitro under physiological conditions from tryptamine in the 
presence of serine and FH4 using partially purified SHMT. Methy-
lenetetrahydrofolate, which is formed by this reaction, can non-
enzymatically decompose into FH4 and formaldehyde (HCHO). The 
latter substance can react with indoleamines forming THBC 1 s via 
the Pictet-Spengler reaction, probably because other enzymes of 
the one-carbon cycle are not present in this preparation. Never-
theless, an increased conversion of serine into glycine in vivo 
may also result in the formation of beta-carbolines (Mcisaac, 
1961). The present results indeed show that norharman (NH) is 
formed in porphyric rats after serine injection, but instead of 
norharman one would rather expect the formation of THBC or of 6-
hydroxy-THBC from the physiological substances tryptamine and 5-
hydroxytryptamine respectively. An explanation might be that the 
concentration in plasma of hydrogenated precursors of NH do not 
reflect concentrations in tissues where these compounds are for-
med. One may therefore assume that dehydrogenation of the formed 
THBC, which is known to occur in rats (Greiner and Rommelspacher, 
1983), accounts for the formation of NH. 
There has been some discussion whether determination of 
THBC's in biological samples using extraction procedures are 
reliable methods to quantitate these compounds (Eosin et al., 
1983). Careful studies using C-18 reverse-phase sample clean-up 
cartridges in order to minimize the use of organic solvents, 
indicate that these compounds can be determined without any 
measurable artifactual formation of tetrahydro-beta-carbolines 
(Schouten and Bruinvels, 1985). In addition, artifactual dehydro-
genation of THBC's in biological samples has, to our knowledge, 
not been reported to occur during work up procedures. 
The present results show a positive correlation between 
catalepsy and plasma NH concentration as determined immediately 
after measurement of catalepsy. However, a relatively small in-
crease of plasma NH resulted in a large behavioural response. 
Therefore, the question arises whether the plasma concentration 
of NH is causally related to the behavioural phenomena observed. 
It is not inconceivable that NH, which is a very lipophylic 
substance, easily enters the brain resulting in higher concen-
trations of NH in brain as compared to plasma. However, determi-
nation of NH in brains of porphyric rats have to be performed in 
order to support this suggestion. In addition, other substances 
like tetrahydroisoquinolines (THIQs) may be formed under the same 
conditions from catecholamines and these may also contribute to 
the cataleptic behaviour observed (Melchior and Collins, 1982). 
Nevertheless, some behavioural effects of NH resembling the beha-
viour observed in the present study, like a stiff tail, have been 
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found by Morin et aL. (1981, 1984) after i.p. injections of 20 
or 50 mg/kg NH in rats. Using the higher dose, they observed loss 
of righting reflex and a catatonic appearance with stiff and 
extended front and hind limbs. The authors also measured the 
in vivo concentrations of NH in rat brain cortex, which ranged 
from 4-16 uM after i.p. administration of 50-200 mg/kg NH respec-
tively. These results suggest a causal relationship between the 
increased plasma concentration of NH and the cataleptic behaviour 
observed in the present study. However, the brain concentrations 
reported by Morin (1984) are much higher than the plasma concen-
tration of endogenously formed NH in our animal model. 
In conclusion, the present results show that in an animal 
model for acute psychosis using serine treated porphyric rats, a 
correlation was found between NH levels in PRP and the duration 
of catalepsy. In addition these results support the hypothesis 
that endogenous "psychotic" substances can be formed as a result 
of metabolic disturbances in serine and glycine metabolism. This 
metabolic disturbance and the endogenous formation of beta-carbo-
lines are held responsible for the psychedelic symptoms in episo-
dic psychotic patients where the psychedelic symptoms could be 
re-induced in recovered patients by oral administration of serine 
(Bruinvels et al., 1980i Pepplinkhuizen et al., 1980). 
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OCCURRENCE OF THE beta-CARBOLINE NORHARMAN IN PLASMA OF PATIENTS 
DURING EPISODES OF ACUTE PSYCHOSIS. 
by 
M. Joris Schouten, Jacques Bruinvels, Durk Fekkes, 
Udo A.Th. Brinkman and Lolke Pepplinkhuizen. 
Swnmary 
Beta-carbolines have been postulated to be endogenously 
formed in patients suffering from an acute psychosis, accompanied 
by psychedelic symptoms. These patients were diagnosed according 
to criteria described elsewhere. Blood samples were collected 
from 6 patients during an acute psychotic state, as well as from 
3 patients with the same diagnosis, but in a psychotic free 
period, and from 8 healthy controls. Norharman (beta-carboline, 
BC), harman (1-methyl-BC), 1,2,3,4-tetrahydro-beta-carboline 
(THBC), 6-hydroxy-THBC ( 6-0H-THBC), and 6-methoxy-THBC ( 6-MeO-
THBC) were extracted and analyzed using high-preformance liquid 
chromatography (HPLC) with fluorometric detection. A significant 
increase in norharman was found in platelet poor plasma (PPP) 
from acute psychotic patients during a psychotic episode, when 
compared with both patients in a symptom-free period, and healthy 
controls. These differences were not found in platelets. No 
changes of harman, THBC, 6-0H-THBC or 6-MeO-THBC concentrations 
in either platelets or PPP were found. The identity of norharman 
was confirmed using a newly developed liquid chromatography -
mass spectrometry (LC-MS) method. 
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INTRODUCriON 
Since the proposal by Osmond and Smythies (1952) that an 
abberant methylation of catecholamines might be the cause of 
schizophrenic psychoses, the search for psychotomimetic substan-
ces in biological fluids of patients over the past years was 
without success. Although dimethyltryptamine (DMT), a hallucino-
genic derivative of tryptamine, was detected in cerebrospinal 
fluid of schizophrenic patients (Smythies et al., 1979), no dif-
ference between patients and controls was noted. Moreover, a much 
higher concentration of DMT was found in non-psychotic patients 
with liver disease. 
To test the possibility that a disturbed transmethylation of 
catecholamines or of indoleamines can evoke acute psychotic symp-
toms, Follin et al. (1961) administered large doses of methio-
nine, the precursor of the met~yldonor S-adenosylmethionine 
(SAM), to chronic schizophrenic patients for several days. It was 
reported that 40% of the treated patients showed some acute 
psychotic reaction. This investigation was followed by nine other 
studies none of which, however, could convincingly show that 
administration of methionine to chronic schizophrenics was res-
ponsible for schizophrenic symptoms (Cohen et al., 1974). Some 
years later Levi and Waxman (1975) argued that schizophrenic 
patients should have a reduced level of SAM. This was confirmed 
by Carl et aL (1978), who found that the activity of two enzymes 
involved in the biosynthesis of SAM, methionine adenosyltransfe-
rase (Fig. 1, step 3) and serine hydroxymethyltransferase (Fig. 
1, step 1 ), was significantly lower in erythrocytes of schizo-
phrenics as compared to a control group. One may therefore con-
clude that an increased biosynthesis of SAM, concurring with the 
transmethylation hypothesis, is unlikely. Smythies (1984) recent-
ly re-evaluated the transmethylation hypothesis and concluded 
that schizophrenics who respond to methionine-with acute psycho-
tic symptoms are more likely to have an under- than an over-
active methylating system (Fig. 1, step 4). 
It was previously reported (Pepplinkhuizen et al., 1980; 
Bruinvels and Pepplinkhuizen, 1984 and 1985) that a group of 
patients suffering from an episodic psychosis with psychedelic 
symptoms (dysperceptions) may be an example of a group of pa-
tients where endogenous formation of hallucinogenic beta-carbo-
lines occurs (Pepplinkhuizen et al., 1980). Oral administration 
of serine (2 mmol/kg) to these patients, who had adequately 
recovered from acute psychotic attacks, caused a recurrence of 
psychotic symptoms within a few hours. During remissions, these 
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Fig. 1. Flow diagram showing serine metabolism in relation to 
taurine and norharman formation in acute psychotic patients. 
Substances underlined were shown to be altered, while thick lines 
indicate putative preferential pathways in this group of pa-
tients. 
gly = glycine 
ser = serine 
met = methionine 
homocys = homocysteine 
cystath. = cystathionine 
cys cysteine 
tau = taurine 
SAM = S-adenosylmethionine 
SAH = S-adenosylhomocysteine 
FH4 = tetrahydrofolic acid 
CH2=FH4 = S,10-methylene-FH4 
CH3-FH4 = S-rnethyl-FH4 
B12 =vitamin B12 
HCHO = formaldehyde 
patients showed a lower fasting plasma serine level, but a 
higher plasma taurine level (Bruinvels and Pepplinkhuizen, 1984). 
The lower serine level is explained by the enhanced conversion 
into glycine (Fig~ 1, step 1) and by the increased formation of 
taurine via the condensation of serine with homocysteine forming 
cystathionine (Fig. 1, step 7). Recently, evidence was obtained 
for a factor present in the serum of these patients, responsible 
for the metabolic shift of homocysteine from the remethylation 
pathway (Fig. 1, step 2) to the transsulfuration pathway (Fig. 
1, via steps 7 and 8; Fekkes et al, in preparation)~ As a conse-
quence of the increased formation of taurine from serine, less 
homocysteine will be available for the remethylation to methio-
nine (Fig. 1, step 2). This metabolic shift results in higher 
levels of CH3-FH4 and CH2=FH4 (Mudd and Poole, 1975), thus faci-
litating the dissociation of CH 2=FH4 into FH 4 and formaldehyde (Fig. 1, step 5). The latter substance reacts non-enzymatically 
with indolearnines to form tetrahydro-beta-carbolines via the 
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Pictet~Spengler reaction (Fig. 1, step 6). 
Since the finding of an enhanced conversion of serine into 
glycine and the increased formation of taurine indirectly support 
the proposed hypothesis, it was considered important to obtain 
direct evidence by measuring beta~carbolines in the plasma and 
platelets of acute psychotic patients. Therefore, a method deve-
loped recently (Schouten and Bruinvels, 1985) based on extraction 
of beta-carbolines from plasma and platelets, followed by high 
performance liquid chromatography with fluorometric detection, 
was used to measure tetrahydro-beta-carbolines and beta-carbo-
lines in platelet poor plasma (PPP) and in platelets of acute 
psychotic patients. Moreover, the identity of a compound found 
in acute psychotic patients was confirmed using a newly developed 
liquid chromatography/ mass spectrometry (LC-MS) technique after 
derivatization of the compound found. 
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METHODS 
Subiects 
Blood was obtained from 8 healthy subjects with a mean age 
of 27 year (range 17-45), and from 9 patients with episodic 
psychosis, as diagnozed according to criteria described else-
where (Pepplinkhuizen, 1983), of which 6 had an acute psychotic 
episode, and 3 were in a symptom-free period. 
Materials 
Norharman (BC) was obtained from Fluka. PFB.CL was obtained 
from Ventron, Karlsruhe, GFR. The organic solvents were obtained 
from Merck and were of Uvasol quality. 1 ,2,3,4-Tetrahydro-beta-
carboline (THBC), 6-hydroxy-THBC (6-0H-THBC) and 6-methoxy-THBC 
( 6-MeO-THBC) were synthesized according to the method described 
by Vejdelek et aL (1961 ). Reverse phase Sep-pak C-18 cartridges 
were obtained from Waters Ass .. Zorbax BP TM C8 was purchased 
from Chrompack (The Netherlands). Demineralized distilled water 
(demidest) was used as a solvent. 
HPLC-fluorometry 
Sample treatment. Venous blood (30 ml samples) was collected 
in 10 ml Vacutainer Thrombotect tubes containing 2.5% EDTA, 
0.025% 2-chloroadenosine and 7.0% procaine-HCl, to inhibit plate-
let aggregation. These samples were separated into platelet poor 
plasma (PPP, 15 ml) and platelets (3.7 x 109 platelets), and 
stored at -80 °C until extraction. Beta-carbolines were extracted 
into a final volume of 1 ml extraction buffer, according to the 
metho::l described previously (Schouten and Bruinvels, 1985). 
Chromatography. High performance liquid chromatography was 
performed on a HP 1084 B Liquid Chromatograph (Hewlett Packard) 
using a stainless steel column (250 x 4.6 mm) home-packed with 
Zorbax BP TM C8 (7-8 micrometer; Chrompack). A Chrompack 75 x 
2.1 mm Guard Column was used to protect the analytical column. 
The injection volume was 0.2 ml, while buffer flow was kept at 2 
ml/min at a temperature of 45oc. Chromatography was performed 
with a single buffer system containing 25 mM (NH4 )2HP04 and 30 % 
2-propanol in demidest. The pH was adjusted to pH 6.0. The com-
pounds were detected by using an Aminco SPF 500 ratio fluorometer 
fitted with a 35 microliter flow cell. The fluorescence was 
measured using an excitation wavelength of 375 nm (bandwith 15 
nm) and an emission wavelength of 434 nm {bandwith 40 nm). Quan-
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titation was performed by automatic peak area integration using 
the Hewlett Packard 79850B terminal, as described earlier (Schou-
ten and Bruinvels, 1985). 
Liquid chromatography - mass spectrometry (LC-MS) 
Extraction. After chromatography using the method described 
above, the fraction of the HPLC-eluate containing the norharman 
peak (3 ml = approx. 1.5 min) was collected and extracted at pH 
9.0 with 2 x 1 ml ethyl acetate. The organic phase was evaporated 
until dryness, and the residue was derivatized and reanalyzed 
using the HPLC-MS technique described below. 
Derivatization. Derivatization of norharman was performed in 
1 00 microliter ethyl acetate containing 800 microM PFB.Cl and 1 
mM trimethylamine, and was incubated for 30 minutes at 20°C. 
Excess PFB.Cl and other relatively volatile compound were evapo-
rated under vacuum (2 mm Hg) until dryness. 
LC. The mobile phase was delivered using a Gilson (Villiers-
le-Bel, France) Model 320 pump. Samples were introduced using a 
micro injection valve with a 0.5 microliter internal injection 
loop. The stainless steel column (100 x 1.1 mm) was packed with 
RP-6 fully capped Phase Sep reverse phase stationary phase, and 
eluted with acetonitrile, at a flow rate of 25 microliter/min. 
This column was connected on-line with the mass-spectrometer via 
a DLI interface. 
MS. A Finnigan (Sunnyvale, CA, U.S.A.) Model 4021 quadrupole 
mass spectrometer was used, while a Finnegan Model 2100 INCOS 
data system was employed for data acquisition and processing. The 
MS ion-source temperature was 300°C. The direct liquid introduc-
tion (DLI) interface consists of a 35-cm long stainless-steel 
jacket which fits into the solid sample probe of the MS instru-
ment. The LC effluent enters the MS source through a fused silica 
capillary (length 500 mm; 0.16 mm O.D. x 0.05 mm I.D.). This 
capillary was fitted coaxial with a stainless-steel capillary 
(1 /16 in. O.D. x 0.3 mm I.D.). Helium (at an inlet pressure of 1-
2 bar) flowed in between both capillaries into the MS source. 
Technical details of the DLI interface are given elsewhere (Ap-
ffel et al., 1983; Maris et al., 1985). The mass spectrum was 
recorded in the negative chemical ionization mode; using the HPLC 
effluent (acetonitrile) as a reaction gas. 
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RESULTS 
For HPLC analysis with fluorometric detection 30 ml blood 
samples were drawn from episodic psychotic patients during an 
acute psychotic episode, from patients with the same diagnosis 
but in a psychotic-free period and from healthy controls. As can 
be seen from Fig. 2, a compound which co-elutes with norharman is 
found in PPP obtained from an acute psychotic patient, while much 
lower amounts were found in samples, obtained from a recovered 
psychotic patient and from a healthy control. In some cases small 
amounts of harman could be detected in PPP just above the detec-
tion limit (0.1 picomole/ml). However, these amounts were not 
significantly different between the three groups. PPP obtained 
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Fig. 2. HPLC chromatcqrams of patient platelet poor plasma (PPP) 
samples using fluorometric detection (see Methods). A: Standard 
sample, 200 pmol/ compound; B: sample of an acute psychotic pa-
tient; C: Sample of a recovered patient; D: Sample of a healthy 
control subject_ Norhar=norharmane; ATr=change of attenuation of 
emission signal. 
from acute psychotic patients contained 0.54 .±_ 0.1 picomol (mean 
~ SEM) norharman per ml while norharman in PPP from healthy 
controls and symptome-free patients were below limits of detec-
tion (0.17 .±_ 0.03 picomol/ml and 0.11 .±. 0.02 picomol/ml, respec-
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tively; Fig. 3). In platelets from all groups, harman and norhar-
man were below limit of detection. Also, there were no signifi-
cant differences in the levels of THBC, 6-0H-THBC or 6-MeO-THBC, 
extracted from both PPP and platelets between the three groups 
studied (Schouten and Bruinvels, 1985). 
NORHARMAN 
pmol/ml PPP 
0.6 
0. 5 
0.4 
0.3 
0.2 
0.1 
HEALTHV 
CONTROLS 
( 8) 
RECOVERED 
PSYCHOTICS 
( 3) 
r-'- * 
ACUTE 
PSYCHOTICS 
( 6) 
Fig. 3. Norharman (nM + SEM) in platelet poor plasma (PPP) of 
acute psychotic patients (N=6), recovered psychotic patients 
JN=3) and healthy controls (N=8). 
P<O.OOS, Student's t-test. 
The presence of a substance in plasma from acute psychotic 
patients which was chromatographically and fluorometrically not 
distinguishable from the beta-carboline norharman, was further 
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substantiated by LC-MS. Norharman could be derivatized easily 
using pentafluorobenzoyl chloride (PFB.Cl) which reacts with the 
indole nitrogen of norharman yielding a norharman-PFB derivative 
with a molecular weight of 362 (Fig. 4). This compound is very 
stable and could be chromatographed on a RP-6 column using aceto-
nitril as the eluent. The column effluent was introduced on line 
into the ion source of the mass spectrometer and thus served as a 
reaction gas for negative chemical ionization. Under these condi-
tions, approx. 25% of the ion is not fragmented (m/e 362), while 
75% is present as a 342 fragment, probably due to splitting off 
of a hydrogenfluoride (HF) fragment (Fig. 4). This technique 
yielded a detection limit of 1 0 fmole~ norharman-PFB using the 
342 fragment for quantification in the single ion mode. 
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Fig. 4. Mass spectrogram of the norharman-pentafluorobenzoyl (NH-
PFB) derivative (MW 362). 10 nmoles of norharrnan were derivatized 
using the methcd. describErl in this re-port. The residue containing 
the NH-PFB derivative was dissolved in 20 microliter acetonitrile 
of which 0.5 microliter, representing 250 picomole of NH-PFB, was 
intrcd.uced into the LC-MS. Relative intensity was recorded in the 
multiple ion detection mode (MID), using the acetonitrile ef-
fluent as the reaction gas for negative chemical ionization 
(NCI)-
In order to confirm the identity of norharman, as indicated 
in Fig. 2, two eluate fractions, corresponding with the norharman 
peak from either the norharman standard or from a PPP extract 
from a psychotic patient blood sample were extracted, and deriva-
tized with PFB.Cl using the method described above. Fig. 5 shows 
two LC-MS chromatograms measured at m/e 342, using the single ion 
mode (SID). The main peak at m/e 342 of the patient sample had 
the same retention time as the norharman-PFB standard, esta-
blishing that the peak measured using the HPLC-fluorometry method 
indeed represents norharman. The two other peaks in the LC-MS 
chromatogram could not be identified using MID, due to the low 
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concentrations. However, corresponding peaks appeared in the LC-
MS chromatograms of PPP extracts, obtained from healthy controls 
(chromatograms not shown). 
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Fig. 5. HPLC-MS chromato-
gram of norharman-PFB. The 
reconstructed ion current 
(RIC) was recorded in the 
single ion mode (SID), 
using an m/ e of 342. Both 
samples were extracted 
from the corresponding 
HPLC-fluorometry eluate 
and deri vatized as des-
cribed in the Methods. 
Residues were dissolved in 
2 microliter acetonitrile, 
of which 0.5 microliter 
was introduced in the LC-
MS. 
A. Standard NH-PFB 
B. PPP extract from an 
acute psychotic patient. 
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DISCUSSION 
The present results indicate that platelet poor plasma of 
acute psychotic patients, experiencing psychedelic symptoms like 
distorted sensory perceptions (Pepplinkhuizen, 1983), contains 
the beta-carboline norharman. Maximum care was exercised to eli-
minate the possibility of artifactual formation of beta-carbo-
lines (Schouten and Bruinvels, 1985).- The presence of this com-
pound was confirmed by LC/MS after derivatization. These results 
strengthen the original hypothesis that beta-carbolines are for-
med in these patients due to an enhanced serine metabolism 
(Bruinvels et al., 1980, Bruinvels and Pepplinkhuizen, 1985). The 
fact that norharman can be detected in plasma of patients reco-
vered from their psychotic attacks or of heal thy controls sug-
gests that this substance may be responsible for one or more of 
the symptoms occurring during acute psychosis. However, as nor-
harman concentrations, detected in PPP of these patients, are 
relatively low, it has still to be ascertained whether this 
compound is indeed responsible for one or more of these symptoms. 
Norharman was also shown to be significantly increased in 
platelet rich plasma (PRP) of serine-treated porphyric rats 
(Schouten and Bruinvels, 1986). In addition, an exponential, 
positive correlation was found between the duration of catalepsy 
and the norharman concentration. From these results it was con-
cluded that an increased conversion of serine into glycine is 
probably responsible for the formation of norharman. 
Norharrnan has several neuropharmacological effects. It is a 
very potent ligand of the benzodiazepine receptor, evoking rever-
se effects of benzodiazepines ("inverse agonist"; Morin, 1984). 
It has been suggested that beta-carbolines are capable of indu-
cing "anxiety", as opposite to effects of most benzodiazepines 
(Skolnick et al., 1984b). Moreover, norharman inhibits monoamine 
oxidase activity and the reuptake of 5-HT in vitro (Airaksinen 
and Kari, 1981 II). As low platelet MAO-A activity is suggested 
as a biological marker in schizophrenia, these mechanisms could 
be responsible for one or more of the symptoms of the patients 
studied. Further experiments are needed to obtain direct evidence 
for this assumption. 
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GENERAL DISCUSSION 
Introduction 
Many research groups have been putting effort in finding 
biochemical aberrations related to the etiology of psychoses, as 
discussed in Chapter I (Gillin, 1978; Smythies, 1982; Bruinvels 
and Peppinkhuizen, 1984). It has been suggested that excessive 
activity of methylation processes could result in the formation 
of abnormally methylated biogenic amines with hallucinogenic or 
even "psychotogenic" properties (Osmond and Smythies, 1952). 
Until now, these compounds have not been found in significant 
amounts, although some enzymatic abnormalities are present in 
different subgroups (Chapter I). In 1980 Pepplinkhuizen et al. 
published on a group of acute psychotic patients of the manic-
psychedelic type, who showed a disturbance in serine- and glycine 
metabolism. These findings were used as a starting-point for this 
thesis. As described in Chapter I, an animal model was developed, 
based on an enhanced conversion of serine into glycine, in order 
to study the putative formation of beta-carbolines. The presence 
of these compounds was correlated with behavioural disturbances 
in these animals. Moreover, beta-carbolines were measured in 
plasma, prepared from blood from episodic psychotic patients. In 
the following paragraph, results from these studies are discus-
sed. 
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Chemical porphyria in rats. Psychiatric manifestations are 
frequently present during acute intermittant porphyria (AIP). 
These symptoms may even occur during remission and become more 
prominent during an acute attack (Bowman and Rand, 1980). Gold-
berg and Stinnet (1983) reported of a porphyric patient with 
signs and symptoms of an acute psychotic and schizophrenic epi-
sode, resembling the symptoms as described by Peppinkhuizen 
et al., (1980). This patient was subsequently diagnozed as having 
AIP (Goldberg and Stinnet, 1983) . As described by Pepplinkhuizen 
(1983), 10% of a group of acute psychotic patients were also 
suffering from porphyria, probably AIP. It was argued , that an 
increased expenditure of glycine will be the result of acute 
porphyric attacks, as glycine is an ultimate precursor in the 
heme pathway (Chapter I. Therefore, the chemical induction of 
porphyria in rats was used as a method to increase the expendi-
ture of glycine. 
Two types of porphyrinogenic agents were used in the initial 
studies (Chapter II). After injection of lead acetate (25 mg/kg 
Lv.) in combination with phenobarbital (50 mg/k.g i.p.), the 
excretion per 24 hr into urine of delta-aminolevulinic acid (d-
ALA)1 the first product in the heme pathway, showed a 28-fold 
increase, whereas excretion of PEG, the second product in the 
heme pathway, was doubled. When administered simultaneously, lead 
and phenobarbital have a strong potentiating porphyrinogenic 
activity (Maxwell and Meyer, 1976). Lead is a potent inhibitor of 
enzymes containing sulfhydryl groups at the active site of the 
enzyme (Moore et al., 1980). Therefore, the main porphyrinogenic 
activity of lead is probably mediated by the interaction with PEG 
synthase and other enzymes containing sulfhydryl groups at their 
active sides (Moore et al., 1980). The massive increase of d-ALA, 
compared to a relatively low increase of PEG excretion into urine 
after lead + phenobarbital treatment can be explained by induc-
tion of d-ALA by phenobarbital, combined with increased breakdown 
of heme via the P450 system, and an inhibition of PBG synthase by 
lead (Maxwell and Meyer, 1976). The second method to induce 
porphyria consisted of subcutaneous injections of allylisopro-
pylacetamide (AIA) into fasting rats. These rats excreted 4 times 
more d-ALA when compared to controls, while PBG excretion was 
increased 35-fold in these animals. It can be concluded from 
these data that both agents were strongly porphyrinogenic in 
rats, which is in agreement with other results (Maxwell and 
Meyer, 1 976; Marver et al., 1 966). However, the different pro-
files in d-ALA and PBG excretion indicate that these porphyrino-
gens act at different steps in the heme pathway. The porphyrino-
genic action of AIA is mainly exerted by accellerating the break-
down of heme, thereby inducing the activity of d-ALA synthase 
80 
Chapter VI 
(Marver et al., 1966; Stephens et al., 1978; Unseld and De Mat-
teis, 1978). As indicated by the massive increase of PBG excre-
tion, excess d-ALA is mainly converted to PBG via PBG synthase 
after AIA pretreatment. 
Glycine levels in porphyric rats. Due to the enhanced demand 
for glycine during chemical porphyria, glycine levels were nega-
tively, semilogarithmically correlated with the excretion of d-
ALA (Fig 3, Ch. II). It can be concluded from this observation 
that the conversion of serine via serine hydroxymethyltransferase 
(SHMT) will be increased, as serine is the main source for gly-
cine (Arnstein, 1954). Therefore, it would be expected that 
serine plasma levels are also lowered during chemical porphyria. 
However, in AIA pretreated animals serine plasma levels were not 
changed, while in lead + phenobarbital pretreated rats these 
levels were increased (Fig. 2 Ch. II). As SHMT also contains 
sulfhydryl groups at its active site, it is probably inhibited by 
lead (Schirch et al., 1980). Because increased conversion of 
serine into glycine via SHMT is essential in the development of 
an animal model for this type of psychosis, it can be concluded 
from this point of view that AIA pretreatment of rats probably 
represents a more useful animal model for psychosis than pre-
treatment with lead + phenobarbital. 
Serine and glycine administrations in porphyric rats. At 
maximum porphyria, which is 18 hrs after administration of lead+ 
phenobarbital (Maxwell and Meyer, 1976) or 24 hrs after AIA 
administration (Marver et al., 1966), rats were injected with 2 
mmol/kg serine or glycine. Serine plasma levels showed a twofold 
increase 20-30 minutes after serine injections in all pretreated 
rats, whereas an approx. 3-fold increase in glycine plasma levels 
was found 20 min after glycine injections (Chapter II). Serine 
plasma levels were increased only in AlA-pretreated rats 20-60 
minutes after glycine injection, while glycine levels were in-
creased 20 minutes after serine injection. These changes in 
serine and glycine plasma levels were not found in lead + pheno-
barbital pretreated rats, which can be explained by the inhibi-
tion of SHMT by lead, as described above. Moreover, serine- or 
glycine injections in non-pretreated animals did not result in 
increasing glycine- or serine plasma levels, respectively. These 
results indicate that only in AIA pretreated animals the inter-
conversion of serine and glycine via SHMT is enhanced. 
catalepsy scores in porphyric rats after serine- or glycine 
administrations. The main problem which is encountered developing 
an animal model for psychotic behaviour in man is to find a use-
ful parameter which can be used as an indicator for this type of 
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behaviour (Domino, 1976; Stoff et al., 1978; Smythies et al., 
1969). In the group of patients under study, visual dyspercep-
tions and hallucinations are prominent at the onset of the psy-
chotic attack (Pepplinkhuizen, 1983). It could be argued then to 
develop an animal model in which hallucinogenic symptoms are mea-
sured. However, as reviewed by Domino (1976}, there were no 
satisfactory animal models for studying hallucinogenic effects of 
indole compounds at the onset of these studies. Most of the 
existing methods were either nonspecific or very time consuming 
(Domino, 1976). Moreover, the duration of the cataleptic beha-
viour as measured in the porphyric rats did not allow the usage 
of these methods. Other types of behaviour which are frequently 
used as an indication of psychotic behaviour are catatonia and 
catalepsy (Bloom and Segal, 1972; Fisher, 1975; Maxwell, 1968; 
Smythies, 1969). These phenomena can be described as a rigid- and 
non-rigid type of immobility, respectively (Costall and Naylor, 
1974). As many of the patients under study also suffered from 
catatonia at the height of their psychosis, measurement of this 
type of behaviour in rats could be suitable as an indicator for 
psychotic behaviour {Bruinvels et al., 1980). The vertical grid 
test was used in these studies for the measurement of catalepsy 
(Segal et aL, 1977). Cataleptic behaviour was observed in both 
AIA and lead + phenobarbital pretreated animals after glycine 
injection, and only in AIA pretreated animals after serine injec-
tion. As explained earlier, lead could inhibit SHMT, which would 
prevent serine to be converted to glycine in excessive amounts. 
The finding that glycine can evoke catalepsy in porphyric rats, 
and psychotic effects in some of the psychotic patients (Bruin-
vels et al., 1980) appears to be somewhat contradictory to the 
hypothesis that enhanced conversion of serine into glycine will 
produce excessive amounts of CH2 =FH 4 (Chapter I). One would 
expect that SHMT should react in the opposite direction after 
glycine administration (Arnstein, 1954). However, glycine can be 
converted to co 2 and NH 3 by the glycine cleavage system (GCS), 
also using FH4 as a cofactor, which is conVerted into CH2 =FH 4 . 
This appears to be a preferential metabolic pathway of glycine 
metabolism after a sudden increase in glycine concentration. 
It can be concluded from the results discussed above that 
serine or glycine administrations to AIA-porphyric rats may pro-
bably represent a suitable model for studying an episodic, acute 
psychosis as described previously (Bruinvels et aL, 1980; Pep-
plinkhuizen, 1983). As hypothesized in the Introductory part 
(Chapter I), beta-carbolines (THBCs or BCs) or tetrahydroisoqui-
nolines (THIQs) could be formed as a result of excess formalde-
hyde production during the existence of high levels of CH 2 =FH 4 . 
Therefore, it will be most interesting to measure whether these 
82 
Chapter VI 
compounds are actually being formed during catalepsy in these 
porphyric rats. 
Elimination of artifactual formation of beta~carbolines 
during work-up. Formaldehyde is present in many organic solvents 
and in most mammalian tissues and body fluids (Eosin et al., 
1983). Biogenic arnines like indoleamines or catecholamines can 
easily condense with formaldehyde via the Pictet-Spengler reac-
tion forming tetrahydro-beta-carbolines (THBCs) and tetrahydro-
isoquinolines (THIQs), respectively (Chapter I). Therefore, pro-
cedures for extraction of beta-carbolines from mammalian tissues 
using substantial amounts of organic solvent could possibly in-
troduce the artifactual formation of THBCs or THIQs, as studied 
by Basin et al. (1983), and several other research groups (McKen-
na and Towers, 1984; Melchior and Collins, 1982; Airaksinen and 
Kari, 1981 I). In order to avoid these problems, a new method was 
developed in these studies using reversed-phase sample prepara-
tion cartridges for the extraction of beta-carbolines from plasma 
and platelets (Chapter III). Basin et al. (1983) showed that 
artifactual formation still occurred during their alkalinization-
extraction procedure. This could be eliminated by reducing the 
exposure of platelet or plasma samples to alkaline organic sol-
vents. As beta-carbolines are more easily formed at alkaline pH 
(Whaley and Govindachari, 1951), the use of lower pH values 
during extraction (pH 4.0) will inhibit the Pictet-Spengler reac-
tion (Hahn and Ludevig, 1934). However, addition of semicarbazide 
to extraction solvents as a formaldehyde trapping agent remained 
necessary. Using this method, artifactual formation of beta-
carbolines was not detectable. 
Beta-carbolines in plasma and platelets from man and rat. 
Beta-carbolines have been detected by many research groups in 
several tissues and body fluids in man and rat (Chapter I). 
Rommelspacher et al. (1979, 1982) reported that 6-hydroxy-
1,2,3,4-tetrahydro-beta-carboline (6-0H-THBC) was present in rat 
platelets and plasma. As reported in Chapter III, these results 
were only confirmed for human platelets. Opposite to other 
groups, our method could not detect 6-methoxy-THBC (6-MeO-THBC) 
in human or rat plasma and platelets (Chapter I and III). As 5-
methoxy-tryptamine (5-MeO-TA) reacts more readily with formalde-
hyde, forming 6-MeO-THBC, than 5-hydroxy-tryptamine (5-HT, sero-
tonin) or tryptamine (TA, Eosin et al., 1983), data showing the 
presence of 6-MeO-THBC in mammals should be considered with great 
care (Basin et aL, 1983, Chapter III). These considerations are 
supported by the observation that concentrations of THBC and 6-
0H-THBC found in these studies are in accordance with those found 
by other research groups (Chapter III), which also indicates that 
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TA and 5-HT are less prone to react with formaldehyde than 5-MeO-
TA. 
Low amounts of 1-methyl-beta-carboline (1-Me-BC, harman) 
were found in human platelets, which have also been detected in 
unknown quanti ties by Bidder et al. ( 1 979). Harman is thought to 
be biosynthesized by the condensation of tryptamine and acetalde-
hyde (Stahl, 1977). Recent attempts to understand the pharmacolo-
gical and toxicological actions of ethylalcohol have increasingly 
focused on the properties of acetaldehyde, its major metabolite. 
This action involves the condensation of acetaldehyde with cate-
cholamines or indoleethylamines to form THIQs or THBCs, respecti-
vely. An intriguing effect of some of these compounds after 
intraventricular administration to rats was a marked and prolon-
ged increase in voluntary ethanol ingestion (Myers and Oblinger, 
1977; Deitrich and Erwin, 1980). In this way, THIQs and THBCs 
could stimulate their own biosynthesis. 
As a conclusion, some questions related to the analytical 
procedures used to establish the identity of beta-carbolines 
in vivo still exist. Measurable artifactual formation of these 
compounds during extraction, using the method described in Chap-
ter III, could be excluded. The concentrations of beta-carbolines 
found in plasma and platelets from man and rat are in accordance 
with, or lower than concentrations reported by others. 
beta-Carboline concentrations in platelet rich plasma from 
serine-injected porphyric rats. Studies performed by Pearson and 
Turner (1979) showed that THBC can be formed in vitro under 
physiological conditions from tryptamine in the presence of seri-
ne and FH4 using partially purified serine hydroxymethyltransfe-
rase (SHMT). This observation supports the hypothesis that beta-
carbolines can be formed in vivo as a result of increased serine 
to glycine conversion. The present results showed that norharman 
(beta-carboline) is formed in vivo in porphyric rats after serine 
injection (Chapter IV table 3). No significant amounts of 6-0H-
THBC, THBC, 6-MeO-THBC or 1-Me-BC were detected. As norharman is 
not fully saturated, it can not be formed directly by the Pictet-
Spengler reaction. The formation of THBC or 6-0H-THBC from tryp-
tamine or serotonin would be expected, but could not be found 
according to the present results. These compounds could be formed 
as intermediate products, and dehydrogenated quickly by an as yet 
unknown reaction. Although THBC can be metabolized to norharman 
in rats, among other products (Greiner and Rommelspacher, 1983), 
these compounds could not be measured using the present method 
(Chapter IV). 
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Correlation of norharman levels in PRP and duration of 
catalepsy_ An exponential correlation was found between catalepsy 
duration and PRP norhaman levels (Chapter IV, fig. 1 ). The shape 
of the curve in the present study showed a striking similarity 
with the curve found by Pannier and Rommelspacher (1981), who 
measured catalepsy after Lp. administration of 1-40 mg/kg THBC 
to rats. These results indicate that the same type of effect 
could be observed in both studies. However, it can not be ascer-
tained from these results whether the catalepsy as measured by 
Pannier and Rommelspacher, or measured in the present studies, 
was evoked by norharman or THBC, or by both. On the other hand, 
this finding indicates that these behavioural disturbances could 
possibly be evoked by norharman. This was confirmed by results of 
Morin et al. (1981, 1984), who described a rigid catatonic-like 
appearance after i.p. administration of norharman (20 mg/kg), 
which could be abolished by diazepam. Measurement of in vivo 
concentrations in these rats demonstrated that these biological 
effects occur at doses which, during in vitro experiments, occupy 
a large proportion of benzodiazepine receptors (Skolnick et aL, 
1982; Morin et al., 1981). As norharman also competitively inhi-
bits specific binding of [3H]-diazepam in mouse brain homogenates 
at low concentrations (Table 2), it was suggested by Morin et al. 
(1984) that this compound is probably a ligand of the benzodiaze-
pine receptor, with effects opposite to those of diazepam. As 
summarized in Table 1 and 2, nor harman has several in vivo and 
in vitro effects in mammals. However, the in vitro inhibition of 
monoamine oxidase-A in mouse brain (Buckholtz and Boggan, 1977) 
and the reuptake inhibition in rat brain synaptosomes (Komulainen 
et aL. 1980) occurred at a relatively low norharman concentra-
tions. Therefore, a combination of these pharmacological actions 
could also contribute to the behavioural effects observed in the 
present study. As already suggested in Chapter II, probably a 
effects 
Kindled seizures in rats/ 
catatonia 
Convulsions in rats 
5-fold increase in plasma cor-
ticosterone concentration. 
inhibitor 
diazepam 
.05 mg/kg 
dose 
20 mg/kg 
20 mg/kg 
25 mg/kg 
210 urn/kg 
Table 1. In vivo effects of norharman in mammals. 
author 
Morin 1984 
Morin 1984 
Rommelsp. 1981 
Meyer 1976 
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mixture of catatonic and cataleptic behaviour was observed in 
serine treated porphyric rats. These different behavioural pro-
files could imply the participation of different neurotransmitter 
systems (Costall and Naylor, 1974). 
effects oc/rc5o (uM) author 
Inhibition of acetylcholinesterase 100 Skup 1983 
Inhibition of epinephrine binding at 80 Given 1983 
platelet alpha-2 adrenergic receptor 
Inhibition of binding to diazepam 1 .62 Cain 1982 
benzodiazepine receptors 
" 
1.6 Morin 1981 
flunitrazepam 8 Rorrm.elsp. 1981 
Inhibition of reuptake 5-HT 38 Kornulainen 1980 
in rat brain synaptosomes DA 64 
" NA 110 
" 
Inhibition of uptake in human 5-HT 57 Airaksinen 1980 
platelets DA 10 
Monoamine oxidase inhibition in 20 Buckholtz 1977 
mouse brain and liver 
Table 2. In vitro effects of norharman in mammalian tissue. 
Measurement of beta-carbolines in psychotic patients. Using 
the method as described in chapter IIIr beta-carbolines were 
measured in plasma obtained from acute psychotic patientsr from 
patients with the same diagnosis but in a psychosis-free periodr 
and from healthy controls. Norharman was detected only in plasma 
from psychotic patients at a concentration of 0.5 pmole/ml? while 
plasma levels of the other groups were below limit of detection 
(0.1-0.15 pmole/ml). As discussed for the serine-injected por-
phyric ratsr THBC is expected to be an intermediate product in 
the biosynthesis of norharman. However, tetrahydro-beta-carbo-
lines could neither be detected in these patientsr nor in serine-
injected porphyric rats using these methods. As mentioned ear-
lier, Greiner and Rommelspacher (1983) described the metabolic 
fate of THBC after intravenous administration to rats. One of the 
urinary metabolites was norharman, indicating that processes that 
dehydrogenate THBC to norharman are active within the mammalian 
body. 
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A new method for LC-MS determination of norharman extracted 
from plasma extracts. As described in chapter I and III, there is 
some doubt on the excistence of beta-carbolines in vivo, due to a 
lack of specificity of the methods employed, and due to the 
failure to eliminate artifactual formation of these compounds 
during sample preparation. As the identification of norharman was 
based only on a HPLC separation method, combined with fluorome-
tric detection, it was most important to confirm the presence of 
norharman in psychotic patients using mass spectrometry methods. 
As rather low concentrations of norharman were found, a sensitive 
mass spectrometry technigue technique had to be used for the 
detection of norharman, ~negative chemical ionization (NCI). 
However, norharman can not be detected in the picomole range 
using this techinque (unpublished results). Moreover, chromato-
graphy of the alkaloid norharman on HPLC reversed phase mate-
rials, or on GC often resulted in tailing peaks (Sokolowski and 
Wahlund, 1980). Therefore, a derivatization technique has to be 
used which covalently binds norharman to a strong electron captu-
ring molecule. As norharman has a pyridine ring, containing a 
tertiary amine, the secundary indole amine group had to be used 
for the derivatiza·tion reaction. However, the indole nitrogen of 
norharman is quite stable and cannot be derivatized with anhy-
dride reagents like heptafluorobutyryl anhydride, pentafluoropro-
pionyl anhydride or acetic anhydride (unpublished results), which 
are reagents used for deri vatization of the piperidine nitrogen 
of THBCs (Honecker and Rommelspacher, 1978b; Faull et al., 1982; 
Becket al., 1982b; Eosin and Holmstedt, 1982; Rommelspacher 
et al., 1982). Pentafluorobenzoyl chloride is a compound combi-
ning high NCI sensitivity with high reactivity for primary and 
secundary amines. This compound reacted with the indole nitrogen 
under relatively mild conditions, as described in chapter V. This 
yielded a molecule with a molecular weight of 362, which could be 
chromatographed easily with GC-MS (unpublished results) and LC-
MS, and detected using NCI in the femtomole range (Chapter V). 
Norharman as a putative biochemical substrate responsible 
for psychosis. The present results indicate that norharman could 
be detected in significant amounts in plasma of acute psychotic 
patients experiencing psychedelic symptoms like distorted sensory 
perceptions. This observation supports the hypothesis that beta-
carbolines in these patients could be formed as a result of 
enhanced serine to glycine metabolism. The concentrations of 
norharman in patients during psychosis are quite low, and it 
remains to be established whether these concentrations could play 
any role in the development of psychotic symptoms. It can be 
expected that nor harman exerts its "psychotogenic" effects via 
the central nervous system. Plasma norharman levels could there-
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fore be a bad indicator for its levels in the brain. However 1 
norharman does cross the blood-brain barrier (Morin, 1984), and 
if it is not broken down rapidly (Greiner and Rommelspacher, 
1982) 1 plasma norharman concentrations could be a true reflection 
of those in brain. 
The main question is by which mechanism in brain norharman 
exerts its effects in the patients described (Chapter I). Norhar-
man has several in vivo and in vitro effects (Table 1 and 2). 
Catatonia in rats was observed after intraperitoneal injection of 
20 mg/kg norharman (Morin, 1984). This could be prevented by the 
administration of 0.05 rng/kg diazepam, which indicates that the 
in vivo effects are mediated by binding to the benzodiazepine 
receptor. This hypothesis is supported by findings that norharman 
is a very potent ligand of the benzodiazepine receptor in vitro 
(Table 2). Morin (1984) suggested that the catatonic effects are 
mediated through activity at benzodiazepine related sites 1 the-
reby acting as an inverse agonist. Moreover, it has been sugges-
ted that beta-carbolines are capable of inducing "anxiety" in 
primates (Skolnick et al., 1984a). As many of the patients des-
cribed earlier (Pepplinkhuizen, 1983) also suffered from anxiety 
preceding and during their psychotic episodes, it is very temp-
ting to speculate that these phenomena could be mediated through 
the pharmacological action of norharman on the benzodiazepine 
receptor. Also, relatively low amounts of norharman can inhibit 
monoamine oxidase-A activity and the reuptake of 5-HT in vitro. 
Both low platelet MAO activity and dysfunction of central 5-HT 
metabolism may contribute to the typical psychotic symptoma-
tology. Others have suggested that the may be used as biological 
markers in schizophrenia (Chapter I), these pharmacological ef-
fects of norharman could also contribute to the phenomena obser-
ved in the patients studied. 
The finding that this pharmacologically active compound is 
detected in episodic psychotic patients can be considered as a 
novelty in biological psychiatry, and could have implications for 
the diagnostic procedures employed to discriminate between diffe-
rent types of psychoses. These results may open new areas for 
fruitful research into the mechanism of action, the in vivo and 
in vitro formation, the concentrations in different parts of the 
mammalian brain during psychotic episodes in man and rat, and 
into the metabolism of this intrig~ing compound. 
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SUMMARY 
Many research groups have searched for putative biochemical 
substrates responsible for psychosis. As psychosis is apparently 
a heterogenous disease, several biochemical theories on the etio-
logy of this disease coexist. These theories can be divided into 
those hypothesizing enzymatic aberrations as a possible cause for 
some types of psychosis, and those in which the formation of 
hallucinogenic or "psychotogenic" compounds is held responsible 
for the development of this disaese. In Chapter I, a summary is 
given of the current knowledge on this subject. The postulate 
that an increased conversion of serine in~o glycine, resulting in 
increased production of CH2=FH4, could give rise to the produc-
tion of putative psychotogenic beta-carbolines, was used as a 
starting point in this thesis. 
It was investigated in Chapter II whether an increased 
demand for glycine, as postulated to occur in patients who have 
suffered from episodic psychoses accompanied by multiple per-
ceptual distortions, could evoke psychotic reactions. Catalepsy 
was used as a measure for psychosis, and was observed after 
injection of serine or glycine in porphyric rats. catalepsy was 
shown to occur after serine as well as glycine administration in 
2-allyl-2-isopropylacetamide (AIA) pretreated rats, while in lead 
+ phenobarbital pretreated rats only glycine was effective. Admi-
nistration of AIA to rats resulted in a strongly enhanced excre-
tion of porphobilinogen (PBG) in urine, while lead + phenobarbi-
tal pretreated rats showed increased excretion of d-aminolevuli-
nic acid (d-ALA). The lead + phenobarbital pretreated animals 
showed elevated serine plasma levels and lowered glycine plasma 
levels 18 hours after injection, while no significant differences 
in plasma levels of these amino acids were found 24 hours after 
AIA administration. In AIA or saline pretreated animals, but not 
in those pretreated with lead + phenobarbital, glycine formation 
from serine was elevated. It is concluded that the present animal 
model can be used to investigate episodic psychoses. 
In Chapter III, the development of a fast method for extrac-
tion and concentration of tryptamine (TA), 5-hydroxy-TA and 5-
methoxy-TA is described using reverse phase C-18 sample prepara-
tion columns in combination with an ion-pairing reagent. Using 
this method, 1 ,2,3,4-tetrahydro-beta-carboline (THBC), 6-hydroxy-
THBC and 6-methoxy-THBC, the respective reaction products formed 
after reaction of formaldehyde with the primary amines mentioned 
above, and beta-carboline (BC, norharman) and 1-methyl-beta-
carboline (1-Me-BC, harman) could be extracted from human and rat 
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platelets and platelet poor plasma (PPP). A HPLC method combined 
with fluorometric detection was developed for the quantitative 
determination of these compounds in the picomole range. The 
formation of beta-carbolines during the extraction procedure was 
below the limit of detection of the assay procedure. 6-0H-THBC, 
THBC, 1-Me-BC and 5-HT were identified as normal constituents of 
human platelets, whereas only 5-HT and 6-0H-THBC could be identi-
fied in human PPP. In rat platelets and PPP 5-HT, but no THBC's 
could be detected. 
Porphyria was induced in adult male Wistar rats starved for 
24 hrs by s.c. injection of 400 mg/kg allylisopropylacetamide 
(AIA), as described in Chapter IV. The presence of porphyria was 
shown by measuring excretion of delta-aminolevulinic acid (delta-
ALA) and porphobilinogen (PBG) into the urine during 24 hr after 
AIA administration. Plasma levels of glycine, serine and of a 
number of other amino acids were decreased in porphyric rats as 
compared to controls. Intraperitoneal injection of 2 mmol/kg 
serine 24 hr after AIA administration was used as an animal model 
for an acute psychosis, by measuring catalepsy scores 30 min 
after serine injection. The concentration of 5 different beta-
carbolines in platelet rich plasma (PRP) was measured using an 
HPLC-fluorometric method. An increase in the concentration of 
norharman (NH) in PRP, ranging from 0.57 nmoles/1 in control rats 
to 1.88 nmoles/1 in serine treated porphyric rats was found. The 
catalepsy duration was exponentially correlated with the NH con-
centrations in PRP. It is concluded that an elevated conversion 
of serine into glycine via serine hydroxymethyltransferase (SHMT) 
may be responsible for the enhanced NH biosynthesis. 
In a group of patients having recovered from episodic psy-
chotic attacks oral administration of serine precipitated psycho-
tic symptoms within 2-4 hours supporting the hypothesis that an 
increased conversion of serine into glycine results in an accumu-
lation of methylene tetrahydrofolic acid (CH2=FH4) in these pa-
tients (Pepplinkhuizen, 1983). It is well known that CH2=FH4can 
decompose non-enzymatically into tetrahydrofolic acid and formal-
dehyde (Chapter I). The latter substance can react with indole-
amines or catecholamines via the Pictet-Spengler reaction forming 
tetrahydro-beta-carbolines and tetrahydroisoquinolines, respecti-
vely. It is reported in this chapter for the first time that the 
beta-carboline norharman is present in the plasma of acute psy-
chotic patients. This substance was not detectable in plasma 
obtained from healthy control subjects or from symptom-free epi-
sodic psychotic patients. The occurrence of norharman in plasma 
may therefore represent an endogenously formed substance respon-
sible for one or more of the psychotic symptoms of which one may 
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be anxiety. 
It is concluded in Chapter VI that the occurrence of norhar-
man, which is a pharmacologically very active compound, can be 
considered as a very important finding in biological psychiatry. 
These results were supported by the finding that the same com-
pound can be detected in rats during behavioural disturbances 
after chemical enhancement of the conversion of serine into 
glycine, which probably also occurs in acute episodic psychotic 
patients. 
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Veel onderzoeksgroepen over de hele wereld zijn al zo'n 30 
jaar op zoek naar mogelijke biochemische substraten die verant-
woordelijk zouden kunnen zijn voor psychotische aandoeningen. 
Daar deze ziekte een duidelijk heterogeen karakter draagt, be-
staan er ook meerdere biochemische theorieen betreffende de oor-
zaak van psychosen. In grate lijn kunnen deze theorieen worden 
verdeelt in diegene welke een enzymatische afwijking postuleren, 
en diegene waarin de vorming van hallucinogene of "psychotogene" 
stoffen verantwoordelijk worden gesteld voor deze ziekte. In 
Hoofdstuk I wordt een samenvatting gegeven van de huidige kennis 
van zaken van enkele van deze theorieen. De aanname dat een 
toegenomen omzetting van serine in glycine, resulterend in toege-
nomen productie van methylene tetrahydrofoliumzuur (CH2=FH4), de 
productie van mogelijk psychotogene beta-carbolines tot gevolg 
zou kunnen hebben, werd gebruikt als uitgangspunt in dit proef-
schrift. 
In hoofdstuk II is het onderzoek beschreven waarin een 
toegenomen biochemische vraag naar glycine in ratten, zoals ge-
postuleerd in patienten met episodische psychosen vergezeld gaand 
met meervoudige perceptuele stoornissen, psychotische reacties 
zou kunnen oproepen. De duur van de catalepsie werd gebruikt als 
een maatstaf voor psychotische reacties, en werd gemeten in 
porfyrische ratten na toediening van serine of glycine. Deze 
catalepsie werd waargenomen na zowel serine als glycine toedie-
ning in ratten die voorbehandeld waren met 2-allyl-2-isopropyl-
acetamide (AIA), terwijl in ratten, voorbehandeld met lood + 
phenobarbital, dit fenomeen alleen gemeten kon worden na glycine 
toediening. Toediening van AIA aan ratten resulteerde in een 
sterk toegenomen excretie van porfobilinogeen (PBG) in de urine, 
terwijl in lood + phenobarbital voorbehandelde ratten een toename 
te zien gaven in excretie van delta-aminolevulinezuur (delta-
ALA). De ratten voorbehandeld met lood + phenobarbital vertoonden 
18 uur na deze injecties toegenomen serine-, en afgenomen glycine 
bloedspiegels. Er werden geen significante verschillen in bloed-
spiegels van deze aminozuren gevonden 24 uur na AIA toediening. 
In alle ratten, behalve diegene voorbehandeld met load + pheno-
barbital, was de vorming van glycine verhoogd na serine toedie-
ning. Geconcludeerd werd dat het gevonden diermodel gebruikt kan 
worden om psychosen nader te bestuderen. 
In Hoofdstuk III wordt de ontwikkeling beschreven van een 
snelle methode ter extractie vanuit humaan en rattebloedplaatjes 
en plaatjes arm plasma (PPP) en concentrering van tryptamine 
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(TA), 5-hydroxy-TA en 5-methoxy-TA. Hierbij werd gebruik gemaakt 
van reverse-phase C-18 kolommetjes voor monstervoorbereiding, in 
combinatie met een ionpaarvormend reagens. Met behulp van deze 
methode konden 1,2,3,4-tetrahydro-beta-carboline (THBC), 6-hydro-
xy-THBC en 6-methoxy-THBC, welke de respectievelijke reactiepro-
dukten zijn na reactie van formaldehyde met de bovengenoemde 
biogene amines, eveneens worden geextraheerd, evenals beta-carbo-
line {BC, nor harman) en 1-methyl-beta-carboline ( 1-Me-BC, har-
man). Een HPLC methode, gecombineerd met fluorometrische detectie 
werd ontwikkeld voor de guantitatieve bepaling van deze stoffen 
in de orde van picomolen/ml bleed. De artefactuele vorming van 
beta-carbolines gedurende de extractie procedure was beneden de 
detectiegrens van de bepalingsmethode. 6-0H-THBC, 1-Me-BC en 5-HT 
bleken normale bestanddelen te zijn in menselijke bloedplaatjes, 
terwijl alleen 5-HT en 6-0H-THBC kon worden gedetecteerd in 
menselijk PPP. In bloedplaatjes en PPP van ratten kon alleen 5-HT 
worden gedetecteerd. 
Porferie werd geinduceerd in volwassen mannelijke ratten, 
welke 24 uur hadden gevast, door subcutane injectie van 400 mg/kg 
allylisopropylacetamide (AIA), hetgeen is beschreven in Hoofdstuk 
IV. De porferie werd aangetoond door na AIA-injectie de 24-uurs 
urineexcretie te meten van delta-aminolevulinezuur (delta-ALA) en 
porfobilinogeen (PBG). De bloedspiegels van glycine, serine en 
een aantal andere aminozuren bleken verlaagd te zijn in porferi-
sche ratten, in vergelijking met controles. De intraperitoneale 
injectie van 2 mmol/kg serine, 24 uur na AIA toediening werd 
gebruikt als diermodel voor psychose, door 30 minuten na serine-
injectie de duur van de catalepsie te meten, zeals is beschreven 
in Hoofdstuk II.De concentratie van 5 verschillende beta-carbo-
lines in plaatjes rijk plasma (PRP) werd gemeten met behulp van 
bovengenoemde HPLC-fluorometrie-methode. Een toename in de nor-
harman concentratie in PRP werd gemeten, varierend van 0.57 
nanomol/1 in controles, tot 1.88 nanomol/1 in porferische ratten, 
aan welke laatste serine was toegediend. De duur van de catalep-
sie bleek exponentieel gecorreleerd met de norharman concentra-
ties in PRP. Er werd geconcludeerd dat een toegenomen conversie 
van serine naar glycine verantwoordelijk zou kunnen zijn voor de 
toegenomen norharman biosynthese. 
Zeals beschreven door Pepplinkhuizen (Proefschrift 1983), 
kon in een groep patienten, hersteld van episodisch psychotische 
aanvallen, konden deze symptomen binnen 2-4 uur weer worden 
opgewekt door orale toediening van serine. Deze waarneming onder-
steunde de hypothese dat een toegenomen omzetting van serine in 
glycine resulteert in ophoping van CH 2=FH 4. Het is bekend dat 
CH2=FH4 niet-enzymatisch kan ontleden in tetrahydrofoliumzuur en 
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formaldehyde. Deze laatste stof kan reageren met indoleamines of 
catecholamines tot respectievelijk tetrahydro-beta-carbolines of 
tetrahydroisoquinolines. In dit hoofdstuk V wordt voor het eerst 
aangetoond dat de beta-carboline norharman aanwezig is in het 
bloedplasma van acuut psychotische patienten. Deze stof kon niet 
worden aangetoond in plasma van gezonde controles of van symp-
toomvrije patienten. De aanwezigheid van norharman in plasma van 
deze patienten zou kunnen betekenen dat deze stof een endogeen 
gevormde verbinding is met hallucinogene werking, verantwoorde-
lij k voor een of meerdere symptom en van de desbetreffende psy-
chose, o.a. angst. 
In Hoofdstuk VI wordt geconcludeerd dat de aanwezigheid van 
norharman, welke verbinding op zichzelf farmacologisch buitenge-
woon actief is, een belangrijke vinding is op het gebied van de 
biologische psychiatrie. Het zou voor de eerste maal zijn dat een 
endogeen gevormde, mogelij k hallucinogene stof aangetoond is in 
episodisch acuut psychotische patienten, en een mogelijk oorzake-
lijk verband vertoont met een of meerdere symptomen. Deze resul-
taten werden ondersteund door het feit dat dezelfde verbinding 
werd gevonden in ratten tijdens gedragsstoornissen na op chemi-
sche wijze de omzetting van serine naar glycine te verhogen, welk 
laatste verschijnsel waarschijnlijk ook plaatsvindt in voornoemde 
patienten. 
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